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GLIA SPECIFIC INNATE RESPONSES AND THEIR INFLUENCE ON MURINE 
CORONAVIRUS INDUCED ENCEPHALOMYELITIS 
PARUL KAPIL 
ABSTRACT 
Control of viral infections of the central nervous system (CNS) is 
challenging, as the host has to balance anti-viral activity and immune mediated 
damage to non- renewable cells. The present study focuses on the role of glia 
and macrophages in regulating initial viral control and subsequent T cell activity 
in a murine model of neurotropic coronavirus induced encephalomyelitis. As 
induction of IFNα/β, pro- and anti-inflammatory factors depend on activation of 
pattern recognition receptors (PRR), macrophages, microglia and oligodendroglia 
were isolated from the CNS of infected mice to characterize their gene 
expression patterns.  Oligodendroglia did not induce Ifnα/β expression following 
intracranial inoculation of both virus or the PRR agonist poly I:C, consistent with 
limited expression of PRRs and factors critical in the IFNα/β pathway. By contrast, 
induction of Ifnα/β by infected microglia and macrophages coincided with a broad 
and high basal expression pattern of IFNα/β signaling components and a 
protective antiviral state.  Furthermore, an anti-inflammatory property of IFNα/β 
was suggested by abrogation of early Il1ra expression in both microglia and 
macrophage in the absence of IFNα/β signaling. Microglia and macrophages also 
induced a mixture of pro-inflammatory (Il12) and anti–inflammatory (Il1ra, Ym1/2) 
genes, which shape the adaptive immune response. IL12 and Ym1/2 stimulate T 
cells towards IFNγ and IL13 producing cells, respectively. The absence of IL12 
ix 
decreased IFNγ and increased IL10 production, resulting in amelioration in 
clinical disease without altering virus control. Under the influence of distinct T cell 
mediated stimuli both microglia and macrophage retained a mixed pro- and anti-
inflammatory phenotype defined by increased expression of iNos and Arg1, 
respectively. Sustained expression of Arg1 and increased phagocytic activity 
indicated an overall bias towards an anti-inflammatory phenotype with time. 
Finally, analysis of the role of PKR, an IFNα/β induced anti-viral gene, 
demonstrated only a modest direct anti-viral role. Surprisingly however, PKR 
deficiency reduced production of the anti-inflammatory cytokine IL10 by CD4 T 
cells, coincident with increased diffuse demyelination. These results demonstrate 
how a tightly linked network between innate and adaptive responses regulates 
viral control as well as tissue damage and disease in a viral encephalomyelitis 
model. 
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CHAPTER I 
INTRODUCTION 
Various RNA and DNA viruses can infect the Central nervous system 
(CNS) and pose a serious threat as they can induce many different pathological 
outcomes such as encephalitis, meningitis, and demyelination. Viruses can affect 
CNS homeostasis in two ways; 1. They can directly infect and destroy CNS 
resident cells leading to neuronal damage, 2. The immune response to the virus 
can mediate damage to the CNS (Griffin, 2003). Neurotropic viruses generally 
invade the host through peripheral routes, but can enter the (Lipton et al., 
2007)CNS by axonal spread or through the hematogenous route either as free 
virus or by transport in infected cells. Once viruses enter in the CNS, infected 
cells can mount a local innate immune response, which recruits peripheral 
immune responses to control the virus. However, due to the unique physiological 
and immune features of the CNS discussed below, viruses often evade the 
immune system and establish persistent or latent infection. Persistent infection in 
the CNS can be kept under control by the immune system in the absence of 
overt clinical symptoms. However, immune suppression or dysregulation may 
lead to loss of viral control resulting in fatal damage to the CNS. Viruses that can 
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infect the human nervous system include Herpes Simplex Virus-1 (HSV-1), 
Human Cytomegalovirus (HCMV), West Nile Virus (WNV), Poliovirus, Measles 
virus, Rabies virus, Human Immunodeficiency virus (HIV) etc (McGavern and 
Kang, 2011). 
1.1 Host Barriers and Innate Immune Responses Associated With CNS 
Infection  
Controlling virus infections in the CNS is a complicated task for the host 
because of the potentially damaging consequences of immune responses. 
Damage to non-renewable cells of the CNS is associated with increased 
permeability of vascular endothelium and influx of inflammatory cells releasing 
proteolytic enzymes and pro-inflammatory molecules, which can mediate 
cytotoxicity. Not surprisingly, therefore, the CNS is structurally protected by 
meningeal coverings and the blood brain barrier to minimize invasion of micro-
organism as well as peripheral leukocytes. Furthermore, limited expression of 
major histocompatibility (MHC) molecules on CNS resident cells and absence of 
dedicated lymphatic drainage system (Galea et al., 2007) make it difficult to 
initiate adaptive immune responses. Overall, these features protect non-
renewable CNS resident cells from infection as well as an overly active immune 
system. Furthermore, local production of the anti-inflammatory cytokine TGFβ 
and neurotrophins, as well as interactions between microglia and neurons 
through maintain an anti-inflammatory environment in the CNS (Hoek et al., 2000, 
Johnson et al., 1992, Neumann et al., 1998).  
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Nevertheless, following infection CNS resident cells quickly initiate 
expression of innate immune molecules. Glial cells can recognize an array of 
molecular patterns associated with micro-organisms (PAMPs) and endogenous 
danger signals (DAMPs) through receptors collectively known as Pathogen 
Recognition Receptors (PRRs) (Piccinini and Midwood, 2010, Hanke and Kielian, 
2011). Signaling via PRRs leads to induction of a variety of innate inflammatory 
cytokines, type-1 Interferons (IFNα/β), chemokines. Rapid production of IFNα/β 
slows virus replication and constrains dissemination prior to emergence of virus 
specific adaptive immune responses. Furthermore, PRRs such as Toll like 
receptors-3 (TLR3) and IFNα/β induced protein kinase RNA dependent (PKR), 
can induce NFkB pathway, resulting in expression of a variety of pro-
inflammatory genes (Alexopoulou et al., 2001). Although the pattern and 
magnitude varies with specific virus infection and the cell type infected, the most 
commonly induced factors are IL1, IL6, IL12, TNFα, CCL2, CCL5 and CXCL10 
(Griffin, 2003). Furthermore, up-regulation of pro-inflammatory genes triggers the 
recruitment of leukocytes to the CNS (Engelhardt and Ransohoff, 2005, Griffin, 
2003). Lymphocytes are activated in the periphery and restimulated by CNS 
resident cells presenting viral antigen. However, the pattern of pro-inflammatory 
molecules within the CNS can influence the pattern and magnitude of T cell 
cytokine expression. Anti-inflammatory molecules, such as IL10, TGFβ further 
limit the noxious effect of CNS inflammation to prevent tissue damage.  IL10 
primarily acts to suppress macrophages and DC function by inhibiting expression 
of MHC class II and co-stimulatory molecules such as CD80/CD86 and 
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production of proinflammatory cytokines and chemokines, including IL12 (Mosser 
and Zhang, 2008). The successful outcome of an infection thus relies on fine-
tuning between pro- versus anti-inflammatory responses to control the infection 
while minimizing tissue damage.  
1.2  Activation of CNS Resident Cells Following Viral Infection 
Two types of PRR that recognize RNA viruses include endosomal 
receptors, Toll Like receptors (TLRs) and cytoplasmic receptors, Retinoic acid 
inducible gene-I (RIG-I) like receptors (RLRs, MDA5 and RIG-I). Microglia and 
astrocytes are the most prominent cell types in CNS in producing a large array of 
cytokines and chemokines. Microglia are the CNS resident macrophages and act 
as immune sentinels in the CNS. Murine microglia expresses all TLRs (TLR 1-9) 
at basal levels (Bsibsi et al., 2002, Olson and Miller, 2004). Activation of 
microglia by various exogenous and endogenous TLR ligands contributes to their 
either neuroprotective or neurotoxic phenotype. Primary murine astrocytes also 
express a wide variety of TLRs at basal levels, however at lower amounts than 
microglia. Specifically, robust expression of TLR3 in astrocytes under 
physiological conditions indicates their responsiveness against viral infections. 
(Bsibsi et al., 2006, Carpentier et al., 2005, Suh et al., 2009). Neurons and 
oligodendroglia can also express/induce a more limited array of TLRs; however, 
their role in induction of innate immune response following CNS infection is not 
well defined (Bsibsi et al., 2002, Suh et al., 2009). These studies indicate that 
activation of innate immune responses in the CNS is not homogeneous but 
rather tailored according to cell type and environmental cues (figure 1). 
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Figure 1.  Role of TLR Signaling in Glial Cells Following CNS Infection (adapted from Carpentier et al., 2008).  (A) Virus recognition, (B) Glial  Cell Activation, (C) Recruitment and Activation  of Peripheral Cells. Error! No text of specified style in document.  
1.3  Experimental Models to Study Immune Responses in CNS 
Due to limitations in obtaining CNS samples to study human viral CNS 
infection, several experimental viral models have been developed to understand 
mechanism regulating immune responses in the CNS. Among infections 
associated with demyelination are Theiler’s murine encephalomyelitis virus 
(TMEV) infection and neurotropic coronavirus infection. TMEV causes persistent 
infection in microglia and macrophage; infected microglia induce production of 
various innate and co-stimulatory molecules and were able to efficiently process 
and present virus and myelin epitopes to infiltrating CD4 T cells (Olson et al., 
 6
2001). Furthermore, administration of IFNβ resulted in reduced infiltration of 
myelin specific CD4 T cells and reduced demyelination, which was associated 
with increased expression of the anti-inflammatory cytokine IL10 in the CNS 
(Olson and Miller, 2009). Similarly, Stimulation of TLRs on glial cells by Herpes 
Simplex Virus-1 (HSV-1), induces IFNα/β, IL15, TNFα and CCL2 expression 
(Conrady et al., 2010). IFNαβ mediates anti-viral effects by inducing proteins 
such as RNaseL and Protein Kinase R (PKR) (Samuel, 2001). In addition, the 
absence of IL10 prevents the severity of inflammatory responses caused by 
HSV-1 (Dakhama et al., 2009). Furthermore, treatment with both IFNβ and IL10 
in mice infected with HSV-1 resulted in suppression in virus spread and 
prevented corneal inflammation (Minagawa et al., 1997).  
These models indicate that the pattern of innate immune responses 
induced by various viruses is critical in dictating the outcome of an infection. To 
better understand the role of individual resident glia cells in mounting innate 
immune response and shaping the adaptive immune response in the CNS, we 
utilized murine gliatropic coronavirus CNS infection as a model of virus-induced 
encephalomyelitis. 
1.4  Coronavirus (JHMV) Mouse Model to Study Encephalitis and 
Demyelination in CNS 
Coronaviruses (CoV) are the largest positive sense single stranded RNA 
viruses (27-32kb genome). These belong to the group Nedovirales (nedo means 
nested in latin) which are characterized by their production of a nested set of 
mRNA with common 3’ end to express various viral gene products (Figure 2 
 7
MHV replication cycle). Virions are composed of four structural proteins namely 
spike protein (S), enveloped protein (E), membrane protein (M) and nucleocapsid 
protein (N) coated genome (Figure 2). The virus assembles in the Golgi Body 
and accumulates in cytoplasmic membrane-bound vesicles which subsequently 
fuse with the plasma membrane resulting in virus exocytosis (Masters, 2006).  
Coronaviruses are the cause of 1/3 of common colds. While primarily 
infecting the respiratory tract, coronaviruses have also been reported to cause 
CNS infection (Bonavia et al., 1997, Yeh et al., 2004, Xu et al., 2005). The 
biggest outbreak of coronavirus (Severe Acute Respiratory Syndrome- 
coronavirus (SARS-CoV) ) infection was reported in 2002-2003 near Hongkong, 
which soon spread to 23 countries claiming 916 lives (WHO, retrieved 2008- 10-
13). With the exception of SARS CoV, human coronavirus infections have not 
received much attention due to their benign disease course. However, murine 
coronavirus infections of their natural rodent hosts are excellent models to study 
acute hepatitis, respiratory disease and encephalomyelitis associated with 
persistence. Specifically a virus variant of the neurotropic John Howard Muller 
strain of coronavirus (JHMV) has prominently been used to study control of virus 
replication in the CNS and immune mediated demyelination. The monoclonal 
antibody (mAb) selected variant of JHMV designated V2.2-v1 (characterized by 
point mutation and deletion in spike protein), used throughout in this study is 
gliatropic virus. Following intracranial inoculation virus initially replicates in 
ependymal cells and spreads to microglia, astrocytes, and oligodendroglia. 
Neurons are rarely infected. Infectious virus in the CNS peaks at day 5 post-
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infection (p.i.), but is generally controlled by day 21 p.i. in a T cell dependent 
manner (Bergmann et al., 2006). 
 
 
Figure 2.  Mouse Hepatitis Virus (MHV) Replication (Bergmann et al.,2006). 
 
Virus replication leads to activation of glial cells and expression of 
cytokines/chemokines that contribute to disruption of the blood brain barrier 
(BBB) integrity.  The influx of T cells is associated with signs of encephalitis that 
can be observed ∼7 days post infection (p.i.) (Fleming et al., 1986). Infiltrating T 
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cells control infectious virus, although viral antigen and RNA can be detected for 
the life of the rodent (Bergmann et al., 2006).  
1.5  Role of Immune Response Following JHMV: Virus Clearance versus 
Pathogenesis 
1.5.1 Innate immune response following JHMV and their interaction 
with adaptive immune response 
Innate immune response in the CNS: JHMV infection initiates rapid 
induction of pro-inflammatory chemokines and cytokines. Early expression of 
CXCL1 and CCL2 is linked to CNS infiltration of neutrophils and macrophages, 
respectively. Macrophages constitute the major part of total early infiltrates at day 
3, 5, and 7 p.i. Furthermore, abrogation of chemokines, CXCL1, CCL2, CCL5 
and CXCL10 has been reported to prevent infiltration of T cells to the CNS (Liu et 
al., 2001, Glass et al., 2004, Hosking et al., 2009, Savarin et al., 2010). Similarly, 
JHMV infection induces pro-inflammatory cytokines such as IL1β, IL6, IL12, 
TNFα, iNOS (inducible form of nitric oxide synthase) (Parra et al., 1997, Rempel 
et al., 2005). Upregulation of these pro-inflammatory cytokines even in absence 
of cellular infiltrates indicates a direct response of CNS resident cells to JHMV. 
All these cytokines are involved in enhancing leukocyte infiltration to the CNS, 
but can also induce apoptosis. IL12 drives the differentiation of naïve CD4 T cells 
towards IFNγ producing Th1 cells. Treatment with recombinant IL12 has been 
shown to protect from lethal hepatotropic mouse hepatitis virus (MHV) in C57Bl/6 
mice, but not in IFNγ R-/- mice indicating IFNγ dependent protective role of IL12 
during hepatitis (Schijns et al., 1996). To evaluate the specific role of IL12 
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following JHMV infection in CNS, we utilized mice deficient in IL12 only (p35-/- 
mice), mice deficient in IL23 only (p19-/- mice), and mice deficient in both IL12 
and IL23 (p40-/- mice) as described in chapter 4.  
Interferons (IFNs): Initially coronavirus were thought to not to induce 
IFNα/β production. However, the importance of IFNα/β signaling in controlling 
viral dissemination became apparent in vivo following peripheral as well as CNS 
infection of mice deficient in type-1 IFN receptor (IFNAR-/-) (Ireland et al., 2008, 
Cervantes-Barragan et al., 2007). The absence of classical IFNα/β producing 
“plasmocytoid dendritic cells (pDCs)” in the CNS emphasize the importance of 
the ability of CNS resident cells to produce IFNα/β (Serafini et al., 2000). Very 
recently, in vitro and ex vivo studies indicate that microglia/macrophage, dendritic 
cells, and oligodendroglia (N20.1 cell line) can produce IFNα/β following CNS as 
well as peripheral MHV (coronavirus) infection (Rose and Weiss, 2009, Roth-
Cross et al., 2008, Li et al., 2010). However the response of fully differentiated 
oligodendroglia compared to microglia in vivo following virus infection has not 
been studied. Thus, chapter 2 focuses on induction of IFNα/β and its response in 
microglia versus oligodendroglia in CNS following viral infection. 
IFNs play a very important role following infection, not only by inducing 
antiviral genes (RNAseL, Protein Kinase RNA dependent (PKR)), but also by 
regulating immune response via the induction of antigen presentation molecules 
(MHC class I and classII), pro-inflammatory genes (IL12p70, IL6, iNOS) as well 
as anti-inflammatory genes (IL1 receptor antagonist, IL10). We previously 
reported a noncanonicial role of the antiviral gene RNaseL following JHMV 
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infection. This study indicated that while RNaseL does not contribute to overall 
virus replication but rather affects virus control in macrophages and microglia 
following CNS infection. Furthermore, RNaseL-/- mice exhibited accelerated and 
severe demyelination and axonal damage compared to wt mice (Ireland et al., 
2009). To further understand the downstream mechanism of IFNα/β mediated 
anti-viral response, we evaluated the role of another well-studied anti-viral gene; 
PKR in JHMV mediated CNS infection. Chapter 3 focuses to understand the role 
PKR in virus replication as well as in modulating pro- and anti-inflammatory 
cytokines.  
1.5.2  Adaptive immune response  
Both T cell mediated as well as humoral immune responses are pertinent 
to the control of JHMV infection at multiple levels.  
Virus Control: The inability of irradiated mice to clear virus following JHMV 
infection emphasizes the importance of both T as well as B cells. Antigen specific 
CD8 T cells contribute a major part in controlling infectious virus from the CNS 
(Bergmann et al., 1999, Bergmann et al., 1993, Castro and Perlman, 1996, 
Stohlman et al., 1995). CD8 T cells control virus replication in different cell types 
using different effector mediators; virus is controlled in astrocytes and microglia 
by perforin dependent cytolysis, while IFNγ secretion is important in controlling 
virus replication in oligodendroglia (Bergmann et al., 2003, Bergmann et al., 2004, 
Gonzalez et al., 2006, Parra et al., 1999). CD4 T cells also contribute to virus 
control by supporting CD8 T cell function and directly affecting virus replication 
(Savarin et al., 2008, Stohlman et al., 2008). While T cells are indispensible in 
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controlling virus replication, however, virus specific antibodies provide protection 
from recurrence of infectious virus during persistence (Lin et al., 1999). 
Pathology: One of the hallmarks of JHMV infection is demyelination. 
Demyelination was originally thought to be due to cytolytic infection of 
oligodendroglia. However, the absence or sparse demyelination in SCID or 
irradiated mice despite high oligodendroglia infection suggests a contribution of 
adaptive immunity (Wang et al., 1990, Houtman and Fleming, 1996). Restoration 
of demyelination after transfer of spleen as well as purified T cells supports a role 
of T cells in destruction of myelin (Houtman and Fleming, 1996, Fleming et al., 
1993).  
1.5.3  Anti-inflammatory response  
Suppression of infectious virus progresses to persistent infection 
accompanied by chronic ongoing demyelination following JHMV infection 
(Weiner, 1973). The inability to completely eliminate viral antigen and RNA 
suggests an important role of anti-inflammatory responses designed to preserve 
CNS function at the expense of virus persistence. During acute JHMV 
encephalomyelitis anti-inflammatory cytokines IL10 and IL4 are upregulated with 
the same kinetics as pro-inflammatory cytokine IFNγ and TNFα (Parra et al., 
1997). Lack of IL10, but not IL4 resulted in increased morbidity/mortality without 
altering virus clearance (Lin et al., 1998). Furthermore, a reengineered JHMV 
strain to produce IL10 confirmed a protective role of IL10. Increased IL10 
production resulted in reduced microglial activation, expression of pro-
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inflammatory cytokines and chemokines, infiltration of lymphocytes to the brain, 
and demyelination (Trandem et al., 2011). 
The balance between pro- versus anti-inflammatory responses is critical to 
achieve effective viral control, but minimal tissue damage. Activation of microglia 
and macrophages play an important role following JHMV mediated CNS 
infections based on their role as primary innate responders. The plasticity of 
activated pro-inflammatory versus immunomodulatory microglia/macrophage 
thus raises an interest in their respective roles in downregulating the immune 
response as virus is controlled in the CNS. In chapter 5 we explored the 
existence of pro as well as anti-inflammatory phenotypes across CNS resident 
microglia and infiltrating macrophages following JHMV infection. 
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CHAPTER II 
OLIGODENDROGLIA ARE LIMITED IN TYPE I INTERFERON INDUCTION 
AND RESPONSIVENESS IN VIVO 
2.1  Abstract 
Type I interferons (IFNα/β) provide a primary defense against infection. 
Nevertheless, the dynamics of IFNα/β induction and responsiveness by central 
nervous system (CNS) resident cells in vivo in response to viral infections are 
poorly understood. Mice were infected with a neurotropic coronavirus (CoV) with 
tropism for oligodendroglia and microglia to probe innate Antiviral 
Researchponses during acute encephalomyelitis.  Expression of genes 
associated with the IFNα/β pathways were monitored in microglia and 
oligodendroglia purified from naïve and infected mice by fluorescent activated 
cell sorting. Compared to microglia, oligodendroglia were characterized by low 
basal expression of mRNA encoding viral RNA sensing pattern recognition 
receptors (PRRs), IFNα/β receptor chains, interferon sensitive genes (ISG), as 
well as kinases and transcription factors critical in IFNα/β signaling. Although 
PRRs, including CoV RNA sensing Mda5, and ISGs were upregulated by 
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infection in both cell types, the repertoire and absolute mRNA levels were more 
limited in oligodendroglia.  Furthermore, although oligodendroglia harbored 
higher levels of viral RNA compared to microglia, Ifnα/β was only induced in 
microglia. Stimulation with the dsRNA analogue poly (I:C) also failed to induce 
Ifnα/β in oligodendroglia, and resulted in reduced and delayed induction of ISGs 
compared to microglia.  The limited Antiviral Researchponse by oligodendroglia 
was associated with a high threshold for upregulation of Ikkε and Irf7 transcripts, 
both central to amplifying IFNα/β responses.  Overall, these data reveal that 
oligodendroglia from the adult CNS are poor sensors of viral infection and 
suggest they require exogenous IFNα/β to establish an antiviral state.  
2.2 Introduction 
Type I interferons (IFNα/β) are critical innate cytokines that limit viral 
replication and dissemination prior to the emergence of adaptive immune 
responses. In addition to inducing an antiviral state, IFNα/β exert numerous other 
functions including induction of apoptosis, mobilizing innate cells, and regulating 
adaptive immune responses (Barton, 2008, Borden et al., 2007, Stetson and 
Medzhitov, 2006, Vilcek, 2006). As these pleiotropic effects can be detrimental if 
left unregulated, the innate Antiviral Researchponse has to be controlled to 
minimize cell injury and maintain cellular homeostatic functions. Although an 
early IFNα/β response contributes to viral control and disease outcome, its 
precise regulation is especially critical in the central nervous system (CNS), 
where the health of non renewable neurons as well as resident glia is vital for the 
maintenance of host physiological function. IFNα/β production and signaling is 
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thus tightly regulated by both the basal and inducible expression of numerous 
factors involved in the IFNα/β pathway.  
 During viral infections the ability to induce IFNα/β is determined by 
activation of pattern recognition receptors (PRR) following interaction with 
pathogen associated molecular patterns, which typically constitute viral RNA or 
DNA structures.  PRRs comprise members of the Toll-like receptor (TLR) family 
and the cytosolic helicase sensors, retinoic acid-inducible gene 1 (RIG-I) and 
melanoma differentiation-associated antigen 5 (MDA5) (Kawai and Akira, 2009, 
Mogensen, 2009) . PRR recognition of viral RNA triggers the activation and 
nuclear localization of interferon regulatory factors (IRF) IRF3 and IRF7 leading 
to IFNα/β induction. By binding to the IFNα/β receptor secreted IFNα/β initiates a 
signaling cascade leading to transcription of a variety of interferon sensitive 
genes (ISG). ISG encode both direct antiviral factors as well as PRR and signal 
transduction components, such as IRF7 and STAT1 (Borden et al., 2007).  This 
amplification loop thus elevates the ability of cells to induce and respond to 
IFNα/β. In general IRF7 is considered the master switch in IFNα/β induction 
following various viral infections due to its role in amplifying IFNα/β production 
(Honda and Taniguchi, 2006). Since the pattern as well as levels of PRR, IRF 
and IFNα/β receptor expression and activation varies with each cell type, initial 
IFNα/β induction and amplification can be very distinct depending on the cell 
types infected (Colonna, 2007, Stewart et al., 2005). Furthermore, due to the 
potency of IFNα/β in inhibiting viral replication, many viruses have evolved 
mechanisms to antagonize the IFNα/β pathway, either at the induction or 
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signaling level (Levy and Garcia-Sastre, 2001, Sen, 2001). Microglia and 
astrocytes are primary sentinels within the CNS parenchyma responding to 
stimuli triggered by either microbial infection or degenerative events (Dong and 
Benveniste, 2001, Hanisch, 2002, Paul et al., 2007). This function is partially 
attributed to basal expression of a vast array of PRRs (Bsibsi et al., 2002, Carty 
and Bowie, 2011, Hanke and Kielian, 2011, Okun et al., 2009, van Noort and 
Bsibsi, 2009). Irf3 mRNA and to a lesser extent Irf7 mRNA, are constitutively 
expressed in the CNS. While Irf7 expression is highly inducible, Irf3 transcripts 
remain constant following infection (Ousman et al., 2005).  However, their 
relative expression in different cell types has not been extensively explored. 
Consistent with PRR activation, microglia, astrocytes and neurons all induce 
IFNα/β (Paul et al., 2007). However, the vast majority of information on innate 
responses is derived from primary glia and neuronal cultures established from 
neonates and may not reflect responsiveness of fully differentiated cells. Distinct 
from in vitro studies, IFNα/β production in vivo is highly restricted as indicated by 
the small proportion (less than 5%) of infected neurons with detectable IFNα/β 
expression in mice infected with lymphocytic choriomeningitis virus (Delhaye et 
al., 2006). Furthermore, IFNα/β inducible Irf7 transcripts mapped closely to sites 
of viral RNA (Ousman et al., 2005), supporting highly focal IFNα/β responses. 
Overall however, little is known about responsiveness of distinct CNS cell types 
to viral infections in vivo. Specifically oligodendroglia appears to express a limited 
TLR repertoire at basal levels compared to microglia (Hanke and Kielian, 2011, 
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Okun et al., 2009, Paul et al., 2007). They also do not appear to contribute to 
active proinflammatory cytokine secretion (Cannella and Raine, 2004).   
 Infection with the neurotropic mouse hepatitis virus (MHV) strain JHM 
(JHMV), belonging to the positive strand RNA coronavirus (CoV) family, was 
used to better characterize the ability of oligodendroglia to mount innate antiviral 
immune responses in vivo based on its prominent infection and persistence in 
oligodendroglia (Bergmann et al., 2006).  In adult mice JHMV infection causes an 
acute encephalomyelitis, which resolves into a persistent infection of the spinal 
cord associated with demyelination. In addition to oligodendroglia, this virus also 
infects microglia and infiltrating macrophages during acute infection; however, 
neuronal and astrocyte infection is sparse (Ireland et al., 2008).  CoV members 
are poor inducers of IFNα/β in numerous cell types due to their 5’RNA structures 
mimicking self RNA (Daffis et al., 2010, Zust et al., 2011). However, IFNα/β is 
induced in microglia, macrophages, and plasmacytoid dendritic cells (pDC) 
(Cervantes-Barragan et al., 2007, Roth-Cross et al., 2008). Importantly, a 
protective effect of IFNα/β in vivo was highlighted by uncontrolled MHV 
replication in mice deficient in IFNα/β signaling (Cervantes-Barragan et al., 2007, 
Ireland et al., 2008). Furthermore, protection following peripheral MHV infection 
is associated with TLR7 dependent IFNα/β production by pDC (Cervantes-
Barragan et al., 2007).  The naïve CNS is devoid of pDC (Serafini et al., 2000), 
implicating infected glia as primary candidates contributing to protective IFNα/β 
production following CNS infection. This is supported by MDA5 mediated IFNα/β 
production in infected microglia (Roth-Cross et al., 2008). 
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 In the present study we compared the relative IFNα/β responsiveness of 
oligodendroglia and microglia following infection with JHMV or intracerebral 
inoculation of the double stranded (ds)RNA mimic poly (I:C).  Both glia 
populations were isolated directly from the CNS to monitor changes in mRNA 
expression.  The results are the first to imply an inherent block in IFNα/β 
transcription by oligodendroglia, coincided with limited expression of PRR and 
signaling molecules downstream of PRR activation. The dependence of 
oligodendroglia on IFNα/β from other cellular sources to induce an antiviral state 
in vivo highlight the potent monitoring functions of microglia and suggest a 
mechanism to preserve oligodendroglial homeostatic functions. 
2.3 Results 
2.3.1 Limited expression of PRR and signal transduction molecules 
in oligodendroglia  
Induction of IFNα/β by murine CoV is mediated via TLR7 in pDC and via 
MDA5 in microglia/monocytes (Cervantes-Barragan et al., 2007, Roth-Cross et 
al., 2008). Furthermore, both MDA5 and RIG-1 act as PRR in an oligodendroglia 
cell line (Li et al., 2010). However, the expression of these viral sensors in 
oligodendroglia in the adult CNS is unknown. To analyze their capacity to initiate 
innate responses, oligodendroglia and microglia were isolated from spinal cords 
of uninfected PLP-GFP mice by FACS based on their respective CD45- GFP+ 
and CD45lo/int F4/80+ phenotypes (Malone et al., 2008).  Spinal cords were used 
as donor tissue based on higher oligodendroglia yields compared to brains.  The 
potential of mature oligodendroglia to recognize viral RNA in comparison to 
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microglia was assessed by comparing basal transcript levels of genes encoding 
the viral RNA sensors MDA5, RIG-I, TLR3, and TLR7 (Kawai and Akira, 2007).  
Whereas transcription of all four PRR was readily detected in microglia, Mda5, 
Rig-I and Tlr3 transcripts were significantly reduced and Tlr7 was below detection 
in oligodendroglia (Figure 3A). Basal levels of PRR mRNAs are low in the resting 
CNS relative to lymphoid tissue, with the exception of Tlr3 (McKimmie et al., 
2005). Nevertheless, PRR are rapidly upregulated during viral encephalitis 
initiated by Semliki Forest virus, Rabies virus, and Venezuelan Equine 
Encephalitis virus (McKimmie et al., 2005, Sharma and Maheshwari, 2009). 
However, the relative contribution of infiltrating leukocytes versus resident CNS 
cells was not directly assessed. Microglia and oligodendroglia were therefore 
isolated from JHMV infected mice to evaluate upregulation of PRRs during the 
course of infection.  Microglia upregulated Mda5, Rig-I, Tlr3 and Tlr7 transcripts 
2-5 fold over basal levels, with peak expression at days 3-5 post infection (p.i.) 
(Figure 3B).  Relative to the modest fold increase in microglia, Mda5 and Rig-I 
transcripts were vastly increased in oligodendroglia.  Rig-I expression reached 
levels similar to microglia by day 3 p.i. mounting to an ~70 fold increase over 
naïve levels (Figure 3). Nevertheless, Mda5 mRNA levels in oligodendroglia 
remained overall lower compared to microglia. Similarly, mRNAs encoding the 
endosomal PRR TLR3 and TLR7 were also induced in oligodendroglia; however, 
absolute levels remained low and the peak of expression was delayed relative to 
microglia.  Mda5 and Rig-I induction in oligodendroglia, as well as all RNA 
sensing PRR in microglia, correlated with induction of Ifnα and Ifnβ mRNA 
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throughout days 3-5 p.i. in total CNS RNA following JHMV infection (Ireland et al., 
2008, Malone et al., 2008).  
 
 
Figure 3. Oligodendroglia are limited in basal and inducible expression of viral RNA sensing PRRs. 
Microglia and oligodendroglia purified from spinal cords of naïve (A) or JHMV infected (B) PLP-GFP mice 
were assayed for Mda5, Rig-I, Tlr3, and Tlr7 transcripts at the indicated times p.i. Data represent the 
average of 3 separate experiments ± standard error of the mean (SEM). * denotes p≤0.05 comparing 
microglia to oligodendroglia at each timepoint; # indicates p≤0.05 compared  to basal levels for each cell 
population. 
To verify that the increase in PRR transcripts is directly attributed to 
IFNα/β signaling, mRNA expression was assessed in microglia and 
oligodendroglia from naïve and JHMV infected wt and IFNAR-/- mice.  Although 
Mda5 and Rig-I mRNA levels were diminished by 8-9 fold in microglia from naïve 
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IFNAR-/- relative to wt mice, they were only slightly reduced in oligodendroglia 
(Figure 4). These results are reminiscent of previous observations that PRR 
expression in neurons is controlled by basal IFNα/β signaling (Shrestha et al., 
2003).  Importantly, the absence of IFNα/β signaling abrogated upregulation of 
Mda5 and Rig-I transcripts in both microglia and oligodendroglia following JHMV 
infection (Figure 4). Early induction of Mda5 and Rig-I, both classified as ISG, 
thus demonstrated that oligodendroglia respond to exogenous IFNα/β in vivo, 
similar to microglia. IFNα/β thus enhances the potential to recognize invading 
RNA viruses, thereby facilitating early innate responses.  
 
Figure 4. MDA5 and RIG-I upregulation is IFNα/β dependent.  Wt and IFNAR-/- mice infected with JHMV 
were used to compare induction of Mda5 and Rig-I mRNA in oligodendroglia and microglia purified from 
spinal cords.  Data are average of 3 individual experiments ± SEM as described in Fig. 3. * denotes p≤0.05 
comparing wt to IFNAR-/- populations at each timepoint. 
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2.3.2 IFNα/β is not induced in oligodendroglia  
IFNα/β signaling is crucial to prevent dissemination of gliatropic CoV 
within the CNS parenchyma (Ireland et al., 2008).  Furthermore, IFNα/β induction 
in response to CoV infection has been demonstrated in microglia in vitro and in 
vivo (Roth-Cross et al., 2008) as well as in an oligodendroglial cell line (Li et al., 
2010). Given the distinct basal and inducible levels of Mda5 transcripts in mature 
CNS derived glial populations, the contribution of infected oligodendroglia and 
microglia to IFNα/β induction was assessed in vivo by comparing Ifnβ and Ifnα4 
mRNA relative to viral replication in each population.  Viral loads were monitored 
by measuring viral mRNA encoding the N protein, the most abundant viral gene 
in infected cells (Skinner and Siddell, 1983). JHMV-N transcripts prevailed in 
microglia at day 3 p.i., but decreased by days 5 and 7 p.i. (Figure 5A). By 
contrast, although viral mRNA was near detection levels at day 3 p.i. in 
oligodendroglia, the levels increased ∼20 fold relative to microglia by day 5 p.i.  
Despite subsiding by day 7 p.i., viral mRNA levels remained significantly elevated 
relative to microglia. These results not only assured that infected cells were 
recovered by the isolation procedure, but clearly indicated that virus 
predominated in microglia early, but subsequently prevailed in oligodendroglia.  
Concomitant with infection, sparse but detectable basal levels of Ifnβ and Ifnα4 
transcripts increased in microglia (Figure 5 B).  Ifnβ levels were sustained 
through day 5 p.i., while Ifnα4 levels were only transiently upregulated.  The 
contribution of infiltrating infected monocyte derived macrophages (Ireland et al., 
2009) to Ifnα/β induction was also assessed. Viral RNA loads in macrophages 
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were less than 50% of those in microglia and declined with similar kinetics; Ifnα/β 
transcripts reflected the magnitude of viral RNA transcripts similar to microglia 
(data not shown). By contrast, neither Ifnα4 nor Ifnβ mRNA were detected in 
oligodendroglia from naïve or infected mice (Figure 5B), despite higher viral RNA 
loads as well as elevated Mda5 and Rig-I mRNA expression at day 5 p.i. (Figure 
4).  
 
Figure 5. Oligodendroglia do not induce IFNα/β transcripts during JHMV infection. Microglia and 
oligodendroglia purified from spinal cords of naïve or JHMV infected PLP-GFP mice were assessed for (A) 
JHMV-N transcripts or (B) Ifnβ and Ifnα4 transcripts. Data are average values ± SEM of 3 independent 
experiments. BD indicates below detection. * denotes p≤0.05  comparing microglia to oligodendroglia. 
  
 The failure of oligodendroglia to induce Ifnα/β following infection 
suggested that MDA5 and RIG-I are not activated, and/or that downstream 
signaling factors are limiting. PRR signaling requires several mediators including 
the inducible kinase IKKε (also known as Ikbke or Ikki) and the transcription 
factors IRF3 and IRF7. While IRF3 is constitutively expressed IRF7 is induced by 
IFNα/β and amplifies IFNα/β production (Honda and Taniguchi, 2006, Honda et 
al., 2005).  Therefore to investigate the potential for PRR signaling, 
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oligodendroglia were examined for expression of mRNAs encoding IKKε, IRF3 
and IRF7.  All three mRNAs were regulated in a cell type specific manner (Figure 
6). Microglia from naïve mice expressed higher basal Ikkε transcripts, which were 
modestly, but progressively upregulated throughout day 7 p.i. (Figure 6). By 
contrast Ikkε induction was not detected in oligodendroglia until day 7 p.i., at 
which time levels reached those in microglia. Irf3 mRNA was readily detected at 
basal levels in both microglia and oligodendroglia from naïve mice, but remained 
constant or even declined following infection (Figure 6). Lastly, Irf7 transcripts 
were sparse in both microglia and oligodendroglia derived from naive mice 
(Figure 6), consistent with lower basal CNS expression relative to Irf3 (Ousman 
et al., 2005).  However, in contrast to the induction of Irf7 mRNA in microglia by 
day 3 p.i.,  induction was only modest and significantly delayed in oligodendroglia 
following infection (Figure 6).  As the Irf7 gene is an ISG, its upregulation in 
microglia was consistent with IFNα/β upregulation. By contrast, the delayed 
response in oligodendroglia implied more selective ISG induction and/or distinct 
IFNα/β receptor signaling thresholds. 
 
Figure 6. Oligodendroglia are limited in basal and inducible expression of PRR associated signaling 
factors during JHMV infection. Microglia and oligodendroglia from naïve or JHMV infected mice were 
assayed for Ikkε, Irf3 and Irf7 transcripts as indicated in Fig. 3. Data represent the average of 3 separate 
experiments ± SEM. * denotes p≤0.05 comparing microglia to oligodendroglia at each timepoint; # indicates 
p≤0.05 compared to basal levels for each cell population. 
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2.3.3 Oligodendroglia induce ISG delayed relative to microglia 
 Upregulation of the ISGs Rig-I, Mda5, Tlr3 and Irf7 support the notion that 
oligodendroglia respond to IFNα/β following infection. However, optimal induction 
was delayed and absolute levels were not as robust as in microglia.  These 
results suggested that oligodendroglia are exposed to limiting amounts of IFNα/β 
in the microenvironment, or that they are intrinsically more limited than microglia 
in IFNα/β responsiveness. While the first possibility is difficult to address in vivo, 
the second may reflect reduced expression of the IFNα/β receptor  (IFNAR) or 
downstream signaling components.  We therefore assessed regulation of 
transcripts encoding the IFNAR, as well as STAT1 and IRF9, which act 
downstream of IFNα/β signaling. IFNα/β binds a common receptor complex 
consisting of two transmembrane proteins, IFNAR1 and IFNAR2. As IFNAR2 
exists as a transmembrane and soluble isoform generated by alternative splicing 
(Domanski et al., 1995), we than examined basal expression patterns of IFNAR1, 
and both IFNAR2 isoforms in microglia and oligodendroglia.  Basal mRNA levels 
of the Ifnar1 chain were ~2fold higher in microglia compared to oligodendroglia. 
However, transcripts encoding both the soluble as well as the transmembrane 
form of Ifnar2 were more than 5 fold higher in microglia compared to 
oligodendroglia (Figure 7A), suggesting more limited responsiveness of 
oligodendroglia to IFNα/β. Stat1 and Irf9 transcript levels were also elevated in 
microglia compared to oligodendroglia derived from naïve mice (Figure 7B).  
STAT1 is inducible by both IFNα/β and IFNγ, while IRF9 is constitutively 
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expressed in most non CNS cell types (Borden et al., 2007). Consistent with a 
response to IFNα/β Stat1 mRNA indeed increased ~10-fold by day 3 p.i. and 
remained elevated until day 7 p.i. in microglia (Figure 7B).  By contrast, a 
reduced capacity of oligodendroglia to respond to IFNα/β was supported by the 
modest upregulation of Stat1 transcripts at days 3 and 5 p.i.  The prominent 
increase of Stat1 transcripts prominently at day 7 p.i. suggested IFNγ mediated 
upregulation.  Irf9 transcripts were only upregulated 2-fold in microglia by 3 p.i. 
and subsequently declined to or below basal levels (Figure 7B).  Nevertheless, 
despite lower basal levels and apparent constitutive expression, Irf9 transcripts in 
oligodendroglia rapidly increased by ~15-fold at day 3 p.i., but did not increase 
further at day 7 p.i.  Although activation and nuclear localization of STAT1 and 
IRF9 remains to be evaluated, the overall limited basal levels of Ifnar1 and Ifnar2, 
as well as basal and inducible levels of Stat1 and Irf9 transcripts in 
oligodendroglia during JHMV infection, support an overall paucity in ISG 
transcriptional activation.   
 
Figure 7.  Oligodendroglia have limited IFNα/β receptor signaling capacity. Microglia and 
oligodendroglia from naïve or JHMV infected mice were assayed for transcripts encoding the IFNAR1, 
soluble IFNAR2 (IFNAR2s) and IFNAR2 transmembrane (IFNAR2TM) chains (A) or Stat1 and Irf9 transcripts 
(B). Data in (A) represent the average of 2 experiments; data in (B) represent the average of 3 independent 
experiments ± SEM as indicated in Fig. 3. * denotes p≤0.05 comparing microglia to oligodendroglia at each 
timepoint; # indicates p≤0.05 compared to basal levels for each cell population. 
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 The notion of limited ISG transcriptional activation in oligodendroglia was 
further supported by analysis of a subset of ISG encoding factors with anti-viral 
activity.  Basal levels of transcripts encoding protein kinase R (Pkr), and the 
OAS/RNaseL pathway (Oas2), known to modulate translational activity, were all 
elevated in microglia derived from naïve mice relative to oligodendroglia (Figure 
8). Transcripts encoding adenosine deaminase specific for RNA (Adar1), which 
limits viral replication via introduction of RNA mutations (Bass, 1997), were also 
more abundant in microglia (Figure 8).  By contrast, Ifit2 RNA was expressed at 
similar levels in both cell types derived from naïve mice. Importantly, in microglia 
all transcripts, particularly Oas2 and Ifit2 RNA, were rapidly increased to peak 
levels by day 3 p.i. and declined thereafter. With the exception of Oas2, induction 
was also evident at day 3 p.i. in oligodendroglia; however,  increases were most 
prominent by day 7 p.i., yet never reached the peak absolute values observed in 
microglia (Figure 8).  These data demonstrate that oligodendroglia not only 
express lower steady state levels of ISGs, but also upregulate transcription with 
delayed kinetics relative to microglia in response to CoV infection.  Furthermore, 
delayed ISG expression in oligodendroglia supported a more prominent 
responsiveness to IFNγ than IFNα/β.  Overall the data clearly suggest that 
oligodendroglia require paracrine IFNα/β signals to induce ISG during gliatropic 
CoV infection. 
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Figure 8. Delayed induction of anti-viral ISG in oligodendroglia. Microglia and oligodendroglia from 
naïve or JHMV infected mice were assayed for Pkr, Oas2, Adar1, and Ifit2 transcripts as indicated in Fig. 3. 
Data represent the average of 3 separate experiments ± SEM. * denotes p≤0.05 comparing microglia to 
oligodendroglia at each timepoint; # indicates p≤0.05 compared to basal levels for each cell population. 
 
2.3.4 Inability of oligodendroglia to induce Ifnα/β genes is virus 
independent  
To test whether oligodendroglia are intrinsically limited in IFNα/β 
production, or if limited IFNα/β production is specific to JHMV infection, we 
assessed IFNα/β and ISG induction following intracranial injection of the 
synthetic PRR ligand Poly (I:C).  Poly (I:C) is a strong agonist of both TLR3 and 
the RIG-like receptors RIG-I/MDA5 (Alexopoulou et al., 2001, Kato et al., 2006). 
IFNα/β upregulation was initially tested in total tissue to characterize the time 
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course of Poly (I:C) induced IFNα/β responses in the CNS.  Ifnβ expression was 
maximal at 2 hours and Ifnα4 mRNA was elevated between 2 and 12 hours post 
poly (I:C) inoculation (Figure 9).  By contrast, peak induction of the ISGs Ifit1 and 
Ifit2 was delayed until 12 hours (Figure 9).  Cell type specific gene analysis of 
IFNα/β and ISG after intracranial poly (I:C) injection was thus performed in 
purified microglia and oligodendroglia at 4 hours as an intermediate timepoint for 
optimal Ifnα/β expression and at 12 hours.   
 
Figure 9.Kinetics of CNS IFNα/β responses to Poly (I:C). Wt mice were injected intracranially with 200ug 
poly (I:C) to assess kinetics of Ifnβ,  Ifnα4, Ifit1, and Ifit2  mRNA induction in  spinal cords. Data represent 
the mean ± SEM for 3 mice per group; # indicates p≤0.05 compared to basal levels. 
 
In microglia Ifnα4 and Ifnβ transcripts were clearly induced by 4 hours and 
expression of Ifnβ was sustained until 12 hours (Figure 10).  Importantly, the 
levels were 30-40 fold higher than those induced by viral infection (see Figure 5), 
confirming the significantly increased magnitude of the response. Nevertheless, 
Ifnα/β mRNA remained near detection thresholds in oligodendroglia (Figure 10).  
However, Mda5 and Rig-I levels were increased in both cell populations after 
poly (I:C) injection relative to the modest 4-5 fold increases induced by virus 
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infection (Figure 10). Furthermore, similar to the trend observed during infection, 
Rig-I transcripts were significantly increased over Mda5 transcripts in 
oligodendroglia. Nevertheless, Ikkε and Irf7 transcripts were elevated in both 
microglia and oligodendroglia at 4 and 12 hours after poly (I:C) (Figure 10) 
relative to viral injection (Figure 6).  While limiting IFNα/β levels thus clearly 
contributed to suboptimal ISG induction in both glial populations following 
infection, the mechanism(s) underlying the paucity of IFNα/β induction in 
oligodendroglia remains elusive. Representative of antiviral ISG expression, Ifit1 
and Ifit2 mRNA were also significantly increased in microglia at 4 hours, but 
subsided by 12 hours post poly (I:C) administration. By contrast, in 
oligodendroglia Ifit1 and Ifit2 levels induced at 4 hours were maintained at similar 
(Ifit1) or even increased levels (Ifit2) at 12 hours (Figure 10).  Even under these 
conditions of optimal in vivo stimulation, oligodendroglia exhibited tentative and 
delayed ISG induction. These results support the notion that in vivo 
oligodendroglia are intrinsically impaired in inducing IFNα/β in response to 
dsRNA stimuli but also in responsiveness to IFNα/β suggesting an overall 
dampened capacity for innate responses. 
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Figure 10. Distinct in vivo responses of oligodendroglia and microglia to poly (I:C). Microglia and 
oligodendroglia purified from spinal cords at 4 or 12 hours post poly (I:C) injection were analyzed for 
expression of Ifnα4, Ifnβ, Mda5, Rig-I, Ikkε,  Irf7, Ifit1, and Ifit2 transcripts. Data are representative of two 
independent experiments each with 10 pooled mice per experiment. 
2.4 Discussion 
PRR initiated innate responses in the CNS are critical for the induction of 
IFNα/β, as well proinflammatory cytokines and chemokines.  While PRR 
expression and activation in microglia and astrocytes has been extensively 
explored in vitro (Butchi et al., 2010, Carpentier et al., 2008, Jin et al., 2011, So 
and Kim, 2009), PRR expression and associated signaling components in glia in 
vivo are poorly defined, especially in oligodendroglia. In this study we compared 
the capacity of oligodendroglia relative to microglia to mount IFNα/β mediated 
 33 
innate immune responses.  Glial specific responses were monitored within the 
context of the CNS following intracerebral infection of adult mice with gliatropic 
JHMV or injection of poly (I:C). Microglia were prominent inducers of Ifnα/β 
mRNA following infection, consistent with IFNα/β induction in primary microglia 
as well as bone marrow derived macrophages infected with a heterologous MHV 
(Roth-Cross et al., 2008). However, the inability of oligodendroglia to induce 
Ifnα/β mRNA, despite their high load of viral RNA, contrasted with in vitro studies 
demonstrating MDA5 and RIG-I dependent IFNα/β induction in the infected 
N20.1 oligodendroglia cell line (Li et al., 2010). This discrepancy likely reflects 
differences in expression and/or induction of IFNα/β pathway components, rather 
than distinct viral loads, as even poly (I:C) did not induce Ifnα/β in oligodendroglia 
in vivo.  
 The restricted ability of CoV to induce IFNα/β was recently attributed to 
the O-methylated cap structure of the viral RNA, making it difficult for the host to 
distinguish viral from self mRNA (Daffis et al., 2010, Zust et al., 2011). However, 
in contrast to cultured fibroblasts, bone marrow derived DC, astrocytes and 
neurons the ability of pDC, macrophages/microglia, and an oligodendroglia cell 
line to induce IFNα/β via TLR7, MDA5 and MDA5/RIG-I dependent pathways 
(Cervantes-Barragan et al., 2007, Li et al., 2010, Roth-Cross et al., 2008, Zhou 
and Perlman, 2007) suggests sufficient PRR activation by viral RNA structures to 
mediate protective responses in select cell types. Our data indicate that cell type 
specific basal expression, as well as inducible components in the innate signaling 
pathway constitute critical signaling thresholds determining IFNα/β induction. In 
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the adult CNS oligodendroglia differed significantly from microglia in reduced 
basal transcript levels of viral RNA sensing PRRs and Ikkε.  However, basal Irf3 
transcripts were only reduced by ~50%, and Irf7 transcripts were barely 
detectable in either cell population, consistent with higher basal Irf3 than Irf7 
levels observed in whole naïve brains (Ousman et al., 2005).  Reduced basal 
PRR levels in oligodendroglia were reminiscent of sparsely expressed PRRs in 
primary neurons (Carpentier et al., 2008), and supported the superior initiation of 
Ifnα/β responses of microglia. This concept is consistent with the inability of 
primary cultured neurons and astrocytes to induce IFNα/β expression following 
MHV infection (Roth-Cross et al., 2008).    
 Optimal IFNα/β induction requires amplification through IFNAR to elevate 
PRRs and IRF7 (Honda and Taniguchi, 2006, Honda et al., 2005, Malmgaard et 
al., 2002). However, in contrast to Ifnα/β induction, IFNAR signaling was intact in 
oligodendroglia. Although IFNα/β protein was below detection in cell free 
supernatants derived from the JHMV infected CNS by ELISA (data not shown), 
IFNα/β sufficed to up regulate the ISGs Mda5, Rig-I, Stat1, Irf7, Pkr, Ifit2, and 
Adar1 in oligodendroglia.  The ability of IFNα/β to induce ISGs was consistent 
with basal expression of IFNAR chains, as well as basal and inducible levels of 
Stat1 and Irf9 transcripts.  Although induction above basal levels was greater in 
oligodendroglia than microglia for some genes, peak absolute mRNA levels were 
in general lower compared to those reached in microglia at days 3 and 5 p.i., as 
exemplified by Stat1 and Irf7 mRNA. Furthermore, peak expression for many 
genes did not correlate with maximal Ifnα/β mRNA levels, but rather with peak 
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IFNγ secretion at day 7 p.i. (Parra et al., 2010, Phares et al., 2011, Puntambekar 
et al., 2011).  Distinct pattern of ISG expression in oligodendroglia compared to 
microglia may further reside in low Ikkε mRNA levels. In addition to mediating 
PRR signaling, IKKε influences ISG induction through participation in JAK/STAT 
mediated IFNα/β signaling (Pham and Tenoever, 2010, Tenoever et al., 2007). 
Although not as severe as the complete abrogation of ISG induction in STAT1-/- 
mice, IKKε-/- mice lack induction of ~30% of ISGs, including Adar1 (Durbin et al., 
1996, Tenoever et al., 2007). The biological consequences are demonstrated by 
impaired clearance of influenza virus infection by IKKε-/- mice, despite similar 
expression of IL2, IL6, IL12, IFNγ and RANTES and induction of anti-viral 
antibody (Tenoever et al., 2007).  The paucity of Ikkε mRNA and modest, if any, 
increase of Irf7 mRNA in oligodendroglia, despite abundant viral and Mda5 
mRNA upregulation, may partially explain the absence of Ifnα/β expression and 
more selective and delayed ISG induction during infection. However, even the 
strong IFNα/β response elicited in the CNS by poly (I:C) did not overcome the 
inability of oligodendroglia to induce Ifnα/β, despite over 400 fold increases in 
Ikkε and 85-400 fold increases in Irf7 transcripts relative to those induced by 
infection. These results suggest additional restrictions intrinsic to oligodendroglia 
in the initiation of IFNα/β production.  
 The results thus indicate a reliance of oligodendroglia on external 
production of IFNα/β to induce an antiviral state.  This concept is consistent with 
data indicating that microglia are a dominant source of FNα/β within the CNS 
during JHMV induced encephalomyelitis (Roth-Cross et al., 2008). The biological 
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relevance of suboptimal IFNα/β responses is clearly evident from differential viral 
control in both cell types. A direct response to infection by microglia is supported 
by the correlation between peak viral and Ifnα/β mRNA. Furthermore, the early 
decline in viral RNA, prior to infiltration of T cells, indicates autocrine IFNα/β 
contributes to the rapid control viral spread in this cell type.  By contrast, although 
oligodendroglia were initially infected to a lesser extent than microglia, viral RNA 
increased over 2 logs between days 3 and 5 p.i., coincident with the absence of 
Ifnα/β and tentative induction of antiviral ISGs. These data indicate that 
oligodendroglia thus rely largely on T cell effector function, prominently IFNγ, for 
viral control (Parra et al., 2010). Oligodendroglia are indeed highly responsive to 
IFNγ as indicated by upregulation of class I MHC molecules and associated 
antigen processing components during peak IFNγ, but not IFNα/β induction 
during JHMV infection (Malone et al., 2008). Moreover, specific blockade of IFNγ 
receptor signaling on oligodendroglia prolongs JHMV infection in this cell type 
(Gonzalez et al., 2005, Parra et al., 2010). Whether early events favoring robust 
infection of oligodendroglia prior to emergence of T cells, contribute to ultimate 
persistence of JHMV in oligodendroglia, remains to be elucidated.   
 Overall our results demonstrate a limited role of oligodendroglia as both 
inducers of, and responders to, IFNα/β compared to microglia. Limited innate 
antiviral activity may predispose oligodendroglia to be potent responders to IFNγ 
(Gonzalez et al., 2005, Popko and Baerwald, 1999). While there is no evidence 
supporting toxicity of IFNα/β (Akwa et al., 1998), more restricted induction of 
antiviral mediators, especially those also affecting host cell translation, may 
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circumvent apoptosis and guarantee maintenance of critical myelin 
housekeeping functions and survival. Our findings also contradict the hypothesis 
suggesting that virus initiated IFNα/β production by oligodendroglia drives 
inflammatory responses during viral induced demyelinating disease (Lipton et al., 
2007). The low abundance of PRR at basal levels rather provide a mechanism 
underlying the apparent paucity of oligodendroglia to express cytokines during 
multiple sclerosis or other CNS inflammatory conditions (Cannella and Raine, 
2004, Zeis et al., 2008). Our data thus support the notion that oligodendroglia are 
defensive players under inflammatory conditions.  
   
Figure 11. Model for differential innate glia responses to JHMV infection 
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CHAPTER III 
PKR: UNCONVENTIONAL ROLE OF AN ANTI-VIRAL FACTOR FOLLOWING 
CNS INFECTION 
3.1 Abstract 
IFNα/β plays an eminent role in restricting viral tropism and limiting 
dissemination within the CNS following infection with the glia tropic coronavirus 
JHMV. However, which among the many IFNα/β stimulated innate antiviral 
factors are protective in the CNS is largely unknown. RNaseL and Protein Kinase 
RNA dependent (PKR) are the best-characterized innate anti-viral proteins. 
Although the absence of RNaseL resulted in elevated infection of 
microglia/macrophages, it was insufficient to alter overall JHMV control or CNS 
inflammation. Nevertheless, RNaseL deficiency resulted in mortality coincided 
with accelerated demyelination and axonal degeneration, suggesting RNaseL 
activation provides protective effects independent of viral control.  To identify the 
role of other innate antiviral pathways in JHMV pathogenesis, we explored a 
potential contribution of PKR, an inhibitor of host cell translation and modulator of 
NFkB mediated gene transcription using PKR deficient mice (PKR-/-). Infected 
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PKR-/- mice exhibited no defect in expression of Ifnα/β or induced anti-viral 
genes Ifit1 and Ifit2 suggesting no over deficits in the IFNα/β pathway. 
Surprisingly, however, PKR deficiency significantly reduced expression of NFkB 
mediated pro-inflammatory cytokines and chemokines. Viral burden in the CNS 
was initially increased by ~10-fold in PKR-/- mice relative to wt mice, but 
histological examination revealed no discernable differences in viral antigen 
distribution or tropism. Furthermore, virus was subsequently controlled with 
similar kinetics indicating effective CD8 T cell recruitment and function, although 
PKR deficiency was associated with more extensive accumulation of infiltrating 
cells in the perivascular space, Lower Il21 and Il10 expression further suggested 
modulation of CD4 T cell activity in the absence of PKR. Lastly, the onset of 
axonal damage appeared accelerated and demyelination more diffuse in PKR-/- 
mice. Nevertheless, the overall pathology resembled that of wt rather than 
RNaseL-/- mice and the absence of PKR did not result in high mortality. A subtle 
effect of PKR on JHMV pathogenesis was supported by a similar phenotype of 
mice dually deficient in RNaseL and PKR as in single RNaseL-/- mice. In 
summary the results suggest that RNaseL and PKR only exert subtle direct 
antiviral activity during JHMV infection. Moreover, while PKR activation can 
profoundly influence the cytokine/chemokine milieu without overt consequences 
on disease, RNaseL activation mediates protective function by mitigating 
demyelination. 
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3.2 Introduction 
Type-1 IFN signaling initiates transcription of numerous genes resulting in 
an antiviral state characterized by elevated expression of numerous anti-viral 
factors (Borden et al., 2007, Trinchieri, 2010). Many of the antiviral molecules 
directly block viral replication by interfering with translational activity, either by 
degrading viral and host RNA or directly inhibiting protein synthesis. 
Nevertheless, effective antiviral functions differ not only between viruses 
themselves, but also the cell types infected. Moreover, although distinct anti viral 
factors all minimize viral spread, altered cellular transcriptional and translational 
profiles can also significantly impact host cell function, for example resulting in 
apoptosis. The most characterized anti-viral mechanisms are the 2’-5’ 
oligoadenylate synthetase (OAS)/RNaseL and protein kinase double stranded 
RNA (PKR) pathways (Silverman, 2007b, Silverman, 2007a, Garcia et al., 2007). 
Both depend on activation of latent enzymes to be functional, which serves to 
minimize altered cellular functions in non-infected, bystander cells. Cell type 
dependent antiviral function is illustrated by RNaseL dependent control of West 
Nile virus (WNV) in MEF, but RNaseL independent IFNβ mediated virus 
clearance in either peripheral or cortical neurons. Furthermore, increased 
mortality of WNV infected dual RNaseL/PKR-/- mice is attributed to increased 
peripheral infection, but not enhanced virus dissemination to the CNS (Samuel et 
al., 2006). Virus dependent protection is highlighted by impaired control of 
Sindbis virus in the absence of RNaseL and PKR in mouse embryonic fibroblasts 
(MEF) and bone marrow derived macrophages (Ryman et al., 2002), but IFNβ 
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mediated inhibition of dengue virus is independent of the PKR/RNaseL pathways 
(Diamond and Harris, 2001). PKR play a crucial role in antiviral defense following 
vesicular stomatitis virus infection (VSV) in vitro. Furthermore, 100% mortality 
and uncontrolled virus replication was observed in PKR -/- mice following 
intranasal VSV infection (Stojdl et al., 2000). 
 IFNα/β mediated innate responses are also critical for limiting tropism, 
controlling virus spread and preventing mortality following infection with the glia 
tropic, murine coronavirus, JHMV (Ireland et al., 2008). However, the type-1 IFN 
downstream anti-viral factors mediating protection are largely unknown. RNaseL 
plays a modest role in reducing infection of macrophage/microglia, but does not 
alter overall virus clearance in the CNS (Ireland et al., 2009). Surprisingly 
however, RNaseL mediated protection from accelerated axonal damage, 
demyelination and death. The pathological differences, independent of viral 
control, suggested dysregulation of as yet unknown RNaseL functions in the 
CNS during inflammatory conditions.  
 Based on uncontrolled JHMV spread in the CNS in absence of IFNα/β 
signaling, but limited effects of RNaseL, we further explored other antiviral 
mediators by determining the role of PKR.  PKR is an intracellular sensor of 
stress. Viral dsRNA as well as other ligands such as PKR activating protein 
(PACT) and polyanionic molecules such as dextran sulfate, chondroitin sulfate, 
poly (L-glutamine) and heparin can directly activate PKR (Bergeron et al., 2000). 
In addition to viral RNA, some highly structured cellular RNA molecules, such as 
Tumor Necrosis factorα (TNFα) and Interferonγ (IFNγ) mRNA also has been 
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shown to activate PKR (Ben-Asouli et al., 2002, Osman et al., 1999). The ability 
of PKR to respond to multiple stimuli emphasizes its broader role as a signaling 
molecule against different types of physiological stress. Activated PKR depicts 
kinase activity and undergoes autophosphorylation. The main target of 
phosphorylation by activated PKR is the eukaryotic translation initiation factor, 
eIF2α. Phosphorylation of eIF2α leads to inhibition of translation and induction of 
apoptosis in host cells, therefore inhibiting viral replication. PKR also induces 
transcriptional expression of pro-inflammatory genes and IFNα/β by initiating the 
degradation of IkB, inducing IRF1 expression and indirectly mediating STAT1 
phosphorylation. IkB degradation leads to activation of downstream transcription 
factor NFkB (Kumar et al., 1994, Bonnet et al., 2000).  PKR mediated activation 
of NFkB is independent of its kinase activity. The N terminus (AA 1-265) of PKR, 
which includes the dsRNA binding domain (AA 1-181) and third basic domain 
(AA 181-265) has been shown to activate NFkB by directly binding and activating 
the IKK complex (Bonnet et al., 2006). PKR can also associate with TNF receptor 
associated factor (TRAF) to mediate activation of NFkB (Gil et al., 2004). Other 
than inducing pro-inflammatory cytokines, PKR is also demonstrated to be 
involved in inducing anti-inflammatory cytokine IL10 in monocyte/macrophages in 
response to polyI:C, LPS and distinct infections such as mycobacterium, and 
sendai virus (Cheung et al., 2005, Chakrabarti et al., 2008).  Several studies also 
support a link between PKR and cellular immunity. For example, PKR limits HIV 
replication by reducing surface expression of CD4 T cells in vitro in jurkart cells 
(Nagai et al., 1997). PKR affects ability of CD8 T cells to control replication of 
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Lymphocytic Choriomeningitis Virus (LCMV) without altering CD8 T cell their 
effector function (Nakayama et al., 2010). Lastly, impaired proliferation of CD8 T 
cells in response to mitogen stimulation during systemic lupus erythomatosus 
(SLE) is associated with increased PKR activation and therefore reduced protein 
synthesis (Grolleau et al., 2000).  
 PKR is also implicated to participate in neuro-degenerative processes. 
Following poliomyelitis infection PKR deficient mice show no difference in virus 
replication, but were protected from infection mediated extensive spinal cord 
damage (Scheuner et al., 2003). A separate study links PKR activation as an 
early biomarker of neuronal cell death in Alzheimer’s disease (Peel and 
Bredesen, 2003). Contribution of PKR in neurotoxicity was attributed to its ability 
to increase apoptosis by activating fas associated protein with a death domain 
(FADD) and subsequently activating caspase 3 and 8 in recombinant virus 
infected cells as well as in Aβ treated cells and in APPSLPS1 K1 mice 
(Transgenic mouse to study AD) (Gil and Esteban, 2000, Couturier et al., 2010). 
In the EAE autoimmune model of multiple sclerosis, PKR is mainly expressed by 
oligodendroglia, T cells and some macrophages (Chakrabarty et al., 2004). In 
summary, these findings implicate PKR can control numerous aspects of 
immunity ranging from direct antiviral activity via translational inhibition, to 
induction of pro- as well as anti-inflammatory molecules, and modulation of 
adaptive responses.   Moreover, PKR is also demonstrated to contribute in 
neurotoxicity by inducing apoptotic pathway.  
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 In the absence of PKR we observed higher virus titers early during 
infection at day 3, 5 and 7 p.i. following JHMV infection. However, virus in PKR-/- 
mice was subsequently controlled by day 10 p.i., with similar kinetics as in wt 
mice. This indicated an early antiviral effect of PKR, which was overcome by 
effective CD8 T cell function. We were therefore surprised that reduced 
expression of pro-inflammatory cytokines and chemokines such Il6, Ccl5, and 
Cxcl10 had no apparent effect on leukocyte recruitment. Nevertheless, a 
hallmark of infected PKR-/- mice was accumulation of cells in the perivascular 
space. Specifically the distribution of CD4 T cells was skewed towards retention 
in the perivascular space indicating impaired entry into the CNS parenchyma. 
Moreover, in the absence of PKR, CD4 T cells were impaired in IL10, but not 
IFNγ production. While these results all indicated substantial immune modulation 
by PKR, ultimate virus clearance and disease outcome were surprisingly similar 
to wt mice.  
3.3 Results 
3.3.1 PKR deficiency does not alter IFNα/β induction, reduces NFkB 
mediated gene expression and only affects virus replication 
modestly in the CNS following JHMV infection  
PKR is constitutively expressed at low levels and can signal to activate 
IFNα/β after binding to dsRNA. Activated PKR can also bind to and degrade the 
inhibitor of NFkB (IkB), resulting in NFkB activation (Kumar et al., 1994). Once 
activated NFkB translocates to the nucleus and regulates expression of pro-
inflammatory genes. To initially identify the role of PKR in IFNα/β induction and 
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NFkB activation in the infected CNS, we determined the expression of IFNα/β 
and NFkB induced genes using quantitative real time PCR analysis (Figure 12). 
Induction of Ifnα4 and Ifnβ mRNA peaked in spinal cords at day 5 p.i. in both 
mice and declined thereafter. Although Ifnα4 mRNA levels were similar, Ifnβ 
mRNA was reduced at day 5 p.i. in PKR-/- mice. Nevertheless, no differences 
were observed in expression of the Ifit1 and Ifit2 genes, two ISG that are highly 
sensitive to IFNα/β induction. Both Ifit1 and Ifit2 transcripts were highly 
upregulated by day 5 p.i., remained elevated at day 7 p.i., and declined thereafter 
(Figure 12A). By contrast, expression of NFkB induced cytokines and 
chemokines was significantly impaired, albeit not universally (Figure 12B). While 
the proinflammatory genes Ccl2, Il1β, IL6, Tnfα, Ccl5 and Cxcl10 were all 
upreguated in spinal cords of both groups at day 5 p.i., Il6, Ccl5 and Cxcl10 were 
selectively reduced 2-fold in the absence of PKR. Ccl2 and Il1β mRNA levels 
both increased to similar relative levels at day 7 p.i., and subsequently declined, 
demonstrating no overt effect of PKR. Il6 mRNA remained at 50% the levels of wt 
mice and declined with similar kinetics at days 7 and 10 p.i. By contrast, Ccl5 and 
Cxcl10 chemokine mRNAs increased by day 7 in wt mice, but remained low 
throughout days 7 and 10, barely increasing over the day 5 levels in PKR-/- mice. 
By day 7 p.i. PKR-/- mice also exhibited decreased mRNA levels of Tnfα, which 
was sustained throughout day 10 p.i.  
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Figure 12. PKR deficiency resulted in reduced expression of NFkB induced pro-inflammatory genes, 
but does not alter IFNα/β dependent antiviral genes. Expression of NFkB and IFNα/β induced genes 
were determined using Real time PCR analysis. (A) Expression of Ifnα/β and dependent genes Ifit1 and Ifit2 
from spinal cord of PKR-/- mice and wt mice. (B).  Expression of selected NFkB dependent genes, Il1β, Il6, 
Tnfα, Ccl2, Ccl5, and Cxcl10 relative to Gapdh in spinal cords of PKR-/- and wt mice. Data is represented as 
average of n = 3 mice/ group/ time-point ± standard error mean (SEM).* p ≥ .05. 
To determine an affect of PKR on virus replication viral loads in brains and 
spinal cords were determined by plaque assay and PCR, respectively. Infection 
is always initiated in the brain and rapidly spreads to spinal cords, where it 
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preferentially persists. In wt mice, infectious virus peaks at days 3-5 p.i., starts to 
be controlled at day 7 p.i., and is reduced to undetectable levels by plaque assay 
by day 14 p.i. We observed ∼5-10 fold higher virus titers early during the infection 
at days 3, 5 and 7 p.i. in PKR-/- mice compared to wt mice; however, at day 10 
p.i. virus replication was controlled similarly as wt mice (Figure 13). Analysis of 
viral RNA in spinal cords revealed no evidence of an early antiviral effect of PKR. 
Analysis of viral antigen distribution by histology revealed no overt differences in 
either infected cell numbers or cellular distribution (data not shown). However it is 
plausible that infectious virus is higher in the absence of PKR if viral mRNA is 
translated more efficiently. These results indicates that PKR plays a modest anti-
viral role early during the infection, but virus can be cleared with similar efficiency 
as in wt mice once CD8 T cells infiltrate to the CNS (days 7-10 p.i.).  
 
Figure 13. Virus replication in PKR-/- mice is enhanced during early phase of infection but clear with 
similar kinetics as wt mice. Virus replication in brain was determined by plaque assay on brain 
supernatants at indicated time-points post infection. Data is re represented as average of n = 3 mice/ group/ 
time-point ± standard error mean (SEM). (n = 9 mice/group/time-point).Viral RNA was determined in spinal 
cords relative to Gapdh. * p ≥ .05. 
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3.3.2 Increased CNS T cell infiltration, but accumulation of CD4 T 
cells in the perivascular space in the absence of PKR 
Reduced levels of Il6 and T cell attracting chemokines Ccl5 and Cxcl10 
suggested alteration in leukocyte infiltration into the CNS, yet efficient virus 
control contradicted this notion. Therefore, composition of infiltrating cells was 
determined in CNS of PKR -/- and wt mice using FACS analysis for the cell 
specific surface markers. We observed no difference in number of overall 
infiltrates (CD45hi cells) to the CNS in the absence of PKR. Similarly, monocytes 
infiltrating the CNS, characterized by a CD45hi/F4/80+ phenotype, were not 
statistically different between both mouse groups at any time p.i.  consistent with 
similar monocyte recruiting Ccl2 expression. CXCL10 and CCL5 expression is 
reported to attract T cells to the CNS following JHMV infection (Glass et al., 2004, 
Liu et al., 2001). Therefore alterations in T cell accumulation were determined. 
Both CD4 and CD8 T cells accumulate in the CNS to maximal levels between 7- 
10 days following JHMV infection and account for ∼ 60% of total CD45hi infiltrates. 
Compared to wt mice, CD8 T cells were significantly higher at day 7 p.i. and CD4 
T cells at both day 7 and 10 p.i. within brain infiltrates in PKR-/- mice (Figure 14). 
 
Figure 14.  Increased number of infiltrating T cells to the CNS in PKR-/- mice. Number of infiltrating, 
Total lymphocytes (CD45hi), macrophages (CD45hi F4/80+), CD8 T and CD4 T cells derived from the brain 
of infected wt and PKR-/- mice was determined using flow cytometeric analysis. Data is average of three 
separate experiments ± standard error mean (SEM). (n = 9 mice/group/time-point). * p ≥ .05. 
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Potential differences in distribution of leukocytes within the CNS in both 
groups of mice were also analyzed by histochemical analysis of spinal cord 
sections. Hemotoxylin/eosin staining showed accumulation of infiltrating cells in 
the perivascular space at day 7 and day 10 p.i. (Figure 15A). To quantify the 
relative distribution of subtypes of infiltrating lymphocytes, laminin staining was 
used to visualize the endothelial cells and parenchymal basement membrane to 
define the outer and inner layers of perivascular space where leukocyte 
accumulate before trafficking to the parenchyma of the CNS (Savarin et al., 
2010). Monocytes have been reported to enhance perivascular accumulation of 
lymphocytes (Savarin et al., 2010). However, we did not detect any difference in 
either recruitment of monocyte (Figure 14) or function of monocyte determined by 
phagocytic ability (data not shown). Furthermore, only a transient increase in 
CD8 T cell numbers was observed at day 7 p.i. and similar virus control  at day 
10 p.i. in PKR-/- mice compared to wt (Figure 14) suggested no defect in their 
functional ability. We specifically focused on CD4 T cells based on their 
increased numbers at both day 7 and 10 p.i. To distinguish CD4 T cells 
accumulated in perivascular space compared to total infiltrating CD4 T cells in 
the spinal cord, sections were stained for laminin and CD4 T cells.  In wt mice, 
CD4 T cells preferentially accumulate in perivascular space at day 7 p.i., 
accounting to ∼50% of total CD4 T cells in the perivascular space,  eventually 
CD4 T cells migrate to the parenchyma at day 10 p.i. as observed only ∼20% 
CD4 T cells retaining in the perivascular space while ∼80% localize in 
parenchyma at this time p.i. (Figure 15B). In the absence of PKR, the frequency  
 50 
 
Figure 15.  Trafficking of lymphocytes from perivascular space to CNS parenchyma is influenced in 
PKR-/- mice compared to wt mice. (A) Cross-sections of spinal cords at day 10 p.i. were stained  for 
Hematoxylin and Eosin (H & E). Enhanced perivascular inflammation is consistent with increased T cell 
accumulation by flow cytomteric analysis. Data is representative of three separate experiments. (B) 
Accumulation of CD4 T cells in the perivascular space was determined using staining spinal cord sections 
with CD4 and laminin in PKR-/- mice relative to wt mice. Staining of CD and laminin indicates the 
perivascular accumulation of CD4 T cells. Data is representative of n = 3 mice/ group at day 10 p.i. 
Quantification of frequency perivascular CD 4 T cells within total infiltrating Cd $ T cells is presented as 
graph form. Data is average of total 15 sections between n = 3mice/group/time-point ± SEM. (C) Expression 
of activated PKR in infiltrating CD4 T cells to the CNS was determined by double staining spinal cord 
sections for PKR-p and CD4 in wt mice. Data is represtative of n = 3mice/group at day 7 p.i. * p ≥ .05. 
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of perivascular CD4 T cells was elevated to ∼70% at day 7 p.i., which was 
decreased to ∼50% at day 10 p.i. but still remained significantly higher than wt 
mice. (Figure 15B). Therefore first time we demonstrate that PKR can influence 
CD4 T cells migration across the glia limitans following JHMV infection. To 
identify direct role of PKR in regulation of CD4 T cell function, first we analyzed if 
CD4 T cells express activated PKR (phosphorylated-PKR [PKR-p]) following 
JHMV infection by utilizing fluorescent microscopy on spinal cord sections.  
Positive staining for PKR-p in some CD4 positive T cells indicate that not all CD4 
T cell can express activate PKR (PKR-p) under viral infection (Figure 15C).  
3.3.3 Absence of PKR influences CD4 T cell function 
PKR has been implicated in regulating IL10 production in monocyte and 
CD8 T cell antiviral function (Nakayama et al., 2010, Cheung et al., 2005, 
Chakrabarti et al., 2008), however its effect on CD4 T cell has not been explored. 
Co-expression of activated PKR in CD4 T cells, and increased retention of CD4 T 
cells in perivascular space in absence of PKR would indicate a defect in CD4 T 
cell function in PKR-/- mice. To investigate the effect of PKR on CD4 T cell 
activity, expression of cytokines mainly produced by CD4 T cells during JHMV 
infection was determined using real time PCR analysis. Following JHMV infection, 
IFNγ is produced by both CD4 as well as CD8 T cells, while IL10 is produced at 
high level by CD4 T cells and at lower extent by CD8 T cells (Puntambekar et al., 
2011) and IL21 is mainly secreted by CD4 T cells (Phares et al., 2011). The 
absence of PKR did not affect production of IFNγ at either mRNA (Figure 16A) or 
protein level in the CNS following virus infection. However, Il10 (∼ 6-7 fold) as 
 52 
well as Il21 (∼ 2 fold) transcripts were reduced at day 7 and 10 p.i. in PKR-/- mice 
compared to wt mice (Figure 16A). 
 
Figure 16.  CD4 T cell function is specifically affected in PKR-/- mice relative to wt mice. (A) Effector 
function of CD4 T cells was assessed by measuring mRNA expression of cytokines mainly produced by 
CD4 T cells following JHMV infection (high IFNγ, high IL10 and IL21). Data is represented as average of n = 
3 mice/group/time-point ± SEM. (B) Ability of CD8 and CD4 T cells to produce IFNγ and IL10 was 
determined using intracellular cytokine assay in splenocytes after stimulation with CD * and CD4 specific 
peptides, S510 and M133, respectively. Frequency of IL10 producing CD4 T cells is presented as 
representative flow graph and data is also quantified as average of n = 3/group ± SEM. Reduced effector 
functions associated primarily with CD4 T cells suggests reduced IL10 may contribute to enhanced 
pathology. * p ≥ .05. 
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Reduced expression of Il10 and Il21 in CNS following JHMV infection 
indicates a defect in CD4 T cell to produce these cytokine in the absence of PKR. 
To verify a role of PKR in modulating CD4 T cell function, CD4 T cells were 
activated by peripheral infection and analyzed for cytokine secretion. C57Bl/6 
mice were intra peritoneal injected with DM strain of JHMV (plaque variant of 
JHMV), which produces excellent peripheral response (Stohlman et al., 2008). 
Splenocytes were isolated 7 days p.i. and stimulated with MHC class II M133 
peptide for 5 days to bias composition of spleen cells towards CD4 T cells 
enriched phenotype. Following restimulation with M133 peptide for 6 hours and 
then analyzed for IL10 or IFNγ production by intracellular staining. We observed 
reduced ability of CD4 T cells to secrete IL10 in the absence of PKR, but no 
defect in their ability to produce IFNγ compared to wt mice (Figure 16B). PKR has 
been implicated in regulating IL10 expression in monocytes, however first time in 
this report we demonstrated PKR mediated regulation of IL10 production in CD4 
T cells. 
3.3.4 PKR deficiency results in more diffuse demyelination, but 
does not contribute to clinical disease or survival 
IL10 deficiency results in exacerbated demyelination following JHMV 
infection (Trandem et al., 2011). Due to the significant effects of PKR deficiency 
on IL10 transcription, spinal cords were assessed for myelin loss. Luxol fast blue 
(LFB) staining on cross sections of spinal cords from infected PKR-/- and wt mice 
revealed accelerated and more diffuse demyelination in absence of PKR.  At day 
7 p.i. demyelination was evident by very local vacuolization accompanied by 
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occasional swollen axons within the lesions in wt mice, but lesions were more 
pronounced in the absence of PKR, although axonal loss was not yet evident.  
Demyelination in both groups was more extensive by day 10 p.i.,  but 
more widespread in PKR-/- mice (Figure 17). However, enhanced demyelination 
did not affect progression or severity of clinical disease or survival rate of PKR-/- 
compared to wt mice out to 21 days p.i. (Figure 18). 
 
Figure 17.  Demyelination but not axonal damage increased in PKR-/- mice. The extent of 
demyelination was determined by staining cross sections of spinal cord with Luxoal fast Blue (LFB) from wt 
and PKR-/- mice at day 10 p.i. Data is representative of three separate. 
 
 
Figure 18.  Clinical disease and mortality is not altered in absence of PKR. (Clinical disease and 
survival rate between wt and PKR-/- mice was determined following intrancranial JHMV infection. Data is 
representative of three separate (n ≥ 15 mice/group/time- point ± SEM). 
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3.3.5 Dual deficient mice in PKR and RNaseL depicts overall similar 
phenotype as RNaseL-/- mice 
Studies in mice deficient in either RNaseL or PKR indicated modest, but 
distinct roles in early antiviral function; nevertheless, RNaseL deficiency resulted 
in mortality, while PKR deficiency did not. To evaluate to what extent reduced 
elevated viral titers and reduced early proinflammatory responses by PKR 
deficiency may contribute to pathogenesis in RNaseL-/- mice, mice dually 
deficient in RNaseL and PKR (DRP-/-) were infected with JHMV. The additional 
absence of PKR did not influence mortality, severity or progression of clinical 
disease relative to RNaseL-/- mice (Figure 19A), and ∼80% succumbed to 
infection by day 10-12 p.i. We also observed higher viral burden similar to PKR-/- 
mice by ~10-fold throughout acute infection, although it declined with kinetics 
similar to wt and RNaseL-/- mice (Figure 19B). Higher virus titer even at day 10 
p.i. in DRP-/- mice (Figure 19B) compared to PKR-/- or wt mice (Figure 13) 
indicated an additive effect of the absence of both RNaseL and PKR. To assess 
a defect in T cells potentially contributing to elevated virus titers at day 10 p.i., 
CNS infiltrating cells were examined for number and composition using flow 
cytometry. However, no alterations in either total numbers or composition were 
noted comparing DRP-/- to wt mice (Figure 19C). To confirm a reduction in NFkB 
dependent pro- inflammatory cytokines/ chemokines (Figure 12B), mRNA 
expression of pro-inflammatory cytokines Il6, Tnfα and chemokines Ccl5 and 
Cxcl10 was examined in DRP-/- mice relative to wt mice.  
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Figure 19.  Dually deficient mice in PKR and RNaseL (DRP-/-) demonstrated high virus titers but 
overall similar phenotype as RNaseL-/- mice. (A) Following intracranial JHMV infection, clinical scores 
and survival rate were determined between wt and DRP-/- mice. Data is representative of three separate (n 
≥ 15 mice/group/time-point ± SEM. (B) Virus replication in the CNS of wt and DRP-/- mice following JHMV 
infection. Data are mean of n = 9 mice/group/time-point from three independent experiments ± SEM. And 
(C) Flow cytomteric analysis of bone marrow derived CD45hi infiltrating lymphocytes within the CNS 
following JHMV infection. Total number of CD8 and CD4 T cells isolated from the brains of infected mice. 
Data represents mean from three independent experiments ± SEM. * p ≥ .05. 
 
Surprisingly, we did not observe any defect in expression of either 
cytokines or chemokines in DRP-/- mice compared to wt mice (Figure 20). These 
results indicate that absence of RNaseL rescued from impaired NFkB mediated 
gene expression observed in absence of PKR.  
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Figure 20.  Dual deficiency of PKR and RNaseL reverses PKR mediated reduction in expression of 
NFkB induced pro-inflammatory genes. Expression of NFkB induced genes Il6, Tnfα, Ccl5, and Cxcl10 
were determined relative to Gapdh in spinal cords of DRP-/- mice relative to wt mice, using real time PCR 
analysis. Data is represented as average of n = 3 mice/group/time-point ± SEM. 
 
3.4 DISCUSSION 
PKR and RNaseL are two well-characterized IFNα/β induced anti-viral 
molecules. The absence of RNaseL did not affect overall JHMV clearance from 
the CNS, although virus burden was elevated in CNS derived 
macrophage/microglia (Ireland et al., 2009). Nevertheless, RNaseL deficiency 
resulted in high mortality and accelerated demyelination and axonal damage. 
The limited antiviral effect of RNaseL suggested other anti-viral molecules play a 
more prominent role in preventing initial viral spread throughout the CNS 
following JHMV infection.  PKR was chosen as a candidate based on its ability to 
block translation, but also to indirectly inducing IFNα/β production (O'Malley et al., 
1986). A recent report further suggested that PKR can affect the ability of CD8 T 
cells to control virus replication, but without altering effector function in response 
to LCMV infection (Nakayama et al., 2010). Unlike the LCMV model, the absence 
of PKR did result in higher virus titers early during JHMV infection, but we could 
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not detect a cell type specific effect by histology. Furthermore, there were no 
global defects in expression of IFNα/β or the ISGs, Ifit1 and Ifit2. Similar 
expansion of virus-specific CD8 T cells and kinetics of viral control also ruled out 
alterations in the CD8 T cell response.  
Reduced expression of cytokine/chemokine such as Il6, Tnfα, Ccl5 and 
Cxcl10 in the absence of PKR is attributed to defective transcriptional activation 
of NFkB mediated pro-inflammatory genes (Brain Williams, 1994, PNAS). All 
these genes have been reported to play an important role in recruiting and 
facilitating infiltration of leukocytes through the BBB into the CNS parenchyma. 
Specifically expression of CXCL10 and CCL5 has been shown to facilitate T cell 
recruitment, predominantly CD4 T cells to the CNS following JHMV infection 
(Glass et al., 2004, Liu et al., 2001). It was therefore surprising that the lack of 
PKR resulted in a transient increase in CNS infiltrating CD8 T cells at day 7 p.i. 
and significantly higher number of CD4 T cells at day 7 and day 10 p.i. 
Nevertheless, a large fraction of CD4 T cells accumulated within the perivascular 
space, suggesting they were inhibited from entering the parenchyma, or were 
continuously recruited from the periphery.  Various studies have indicated the 
important role of integrins as well as chemokines in migration of lymphocytes 
across the blood vessels to the perivascular space (Ley et al., 2007). Reduced 
monocyte infiltration also resulted in increased retention of T cells in the 
perivascular space following JHMV infection (Savarin et al., 2010). However, we 
did not observe any deficiency in the monocyte recruiting chemokine Ccl2, 
consistent with similar monocyte infiltration in PKR-/- mice compared to wt mice. 
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The mechanism underlying enhanced perivascular T cell accumulation may 
reside in differential positioning of chemokines (McCandless et al., 2006, 
McCandless et al., 2008, Savarin et al., 2010), or overall reduced 
proinflammatory cytokine/chemokine expression.  
Previous reports have implicated role of PKR in upregulation of the anti-
inflammatory cytokine IL10 in a NFkB, ERK1/2 and JNK1 dependent manner as 
a response to mycobacterium, bacterial lipopolysaccharide, dsRNA and sendai 
virus infection (Chakrabarti et al., 2008, Cheung et al., 2005, McCandless et al., 
2006, McCandless et al., 2008, Savarin et al., 2010).  IL21 has been shown to 
induce IL10 in a mouse model of autoimmunity of systemic lupus erythromatosus 
(SLE) (Spolski et al., 2009) (Roassne spoliski, 2009, JI). In response to JHMV 
infection, both IL10 and IL21 are mainly produced by CD4 T cells (Phares et al., 
2011, Puntambekar et al., 2011). Here we demonstrated for the first time, that 
PKR controls the expression of both IL10 and IL21 in CD4 T cells. The inability of 
CD4 T cells to produce IL10 following ex vivo stimulation with peptide (M133) 
demonstrated that the defect in IL10 was both at the transcriptional and protein 
level. However, IFNγ production by CD4 T cells was not affected and CD8 T cells 
were capable of effective viral clearance in PKR-/- mice indicating that PKR 
specifically affects the ability of CD4 T cells to produce IL21 and IL10. 
PKR also exacerbates pathology in various neurological diseases. Strong 
induction of activated PKR (phosphorylated PKR) in hippocampal neurons has 
been associated with their loss in pathologies associated with Alzheimer’s 
disease, Hutington disease, and Parkinson’s disease (Bando et al., 2005, Peel 
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and Bredesen, 2003). Similarly, the absence of PKR provides protection from 
extensive spinal cord damage during poliomyelitis infection (Scheuner et al., 
2003).  Contrary to these reports, we observed accelerated and more diffuse 
demyelination in absence of PKR following JHMV CNS infection. The enhanced 
pathology observed in PKR-/- mice may be attributed to reduced expression of 
the anti-inflammatory cytokine IL10 (Trandem et al., 2011). IL10 reduces the 
(Lipton et al., 2007)expression of pro-inflammatory cytokines such as IL6, TNFα 
and IFNγ expression in the CNS following JHMV infection (Lin et al., 1998). 
Lastly, although an imbalance between pro- versus anti-inflammatory responses 
in the CNS has been linked to increased severity of clinical symptoms, 
progression of clinical disease and mortality was not altered in PKR-/- compared 
to wt mice. These data supported the notion that IFNγ, which was not altered, 
drives clinical symptoms following JHMV infection. Moreover, double deficient 
mice in PKR and RNaseL demonstrated overall similar phenotype as RNaseL-/- 
mice. This finding would indicate that reduced expression of pro vs anti-
inflammatory response observed in PKR-/- mice was mitigated in absence of 
RNaseL. 
In summary, the absence of PKR contributed to increased viral replication, 
albeit with little consequences on T cell mediated viral control. Surprisingly 
however, PKR deficiency resulted in significantly reduced expression of both pro- 
as well as anti-inflammatory responses, without affecting overall pathogenesis. 
These results are the first to demonstrate numerous effects of PKR at multiple 
levels in CNS resident cells as well as CD4 T cells. While the role of PKR in 
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regulating pro- versus anti-inflammatory responses during CNS infection had no 
overt overall phenotype, its effect in other inflammatory diseases remains to be 
determined.   
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CHAPTER IV 
IL12, BUT NOT IL23, DEFICIENCY AMELIORATES VIRAL ENCEPHALITIS 
WITHOUT AFFECTING VIRAL CONTROL1 
Kapil, P., Atkinson, R., Ramakrishna, C., Cua, D.J., Bergmann, C.C. and 
Stohlman, S.A. 
4.1 Abstract 
The relative contribution of IL12 and IL23 to viral pathogenesis has not 
been extensively studied. IL12p40 mRNA rapidly increases following neurotropic 
coronavirus infection.  Infection of mice defective in both IL12 and IL23 (p40-/-), or 
IL12 (p35-/-) and IL23 (p19-/-) alone, revealed that the symptoms of coronavirus 
induced encephalitis are regulated by IL12. IL17 producing cells never exceeded 
background levels, supporting a redundant role of IL23 in pathogenesis. Viral 
control, tropism, and demyelination were all similar in p35-/-, p19-/- and wild type 
(wt) mice. Reduced morbidity in infected IL12 deficient mice was also not 
associated with altered recruitment or composition of inflammatory cells. 
However, IFNγ levels and virus specific IFNγ secreting CD4 and CD8 T cells 
                                                        
1 This work has been published in the form of a research article (Parul Kapil, 
Roscoe Atkinson, Chadran Ramakrishna, Daniel J. Cua, Cornelia C. Bergmann 
and Stephen A. Stohlman. 2009 . JVI. 83. 5978-5986). 
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were all reduced in the CNS of infected p35-/- mice. Transcription of the pro-
inflammatory cytokines Il1β and Il6, but not Tnf were initially reduced in infected 
p35-/- mice, but increased to wild type levels during peak inflammation. 
Furthermore, although Tgfβ mRNA was not affected, IL10 was increased in the 
CNS in the absence of IL12.  These data suggest that IL12 does not contribute to 
antiviral function within the CNS, but enhances morbidity associated with viral 
encephalitis by increasing the ratio of IFNγ to protective IL10. 
4.2 Introduction 
Resistance to infection, as well as the extent of clinical symptoms, is 
directly influenced by the pattern and magnitude of cytokine induction. 
Specifically, interferon gamma (IFNγ) is closely associated with control of many 
viruses and other intracellular pathogens (Novelli and Casanova, 2004, Scott and 
Kaufmann, 1991). IFNγ secretion in turn is enhanced by interleukin-12 (IL12), 
which in concert with the related cytokine IL23, participates in regulating both 
innate and adaptive immune responses (Hunter, 2005, Langrish et al., 2004, 
Novelli and Casanova, 2004, Jouanguy et al., 1999, Trinchieri, 2003). IL12 is a 
heterodimeric cytokine composed of two subunits (IL12p35 and IL12p40) 
secreted primarily by macrophages and dendritic cells. It is a potent inducer of 
IFNγ secretion by CD4 T cells, even in the presence of T regulatory cells (King 
and Segal, 2005).  It also increases cytokine secretion as well as cytolytic 
potential of NK cells and CD8 T cells (Trinchieri, 2003). IL12 is rapidly induced in 
the periphery and the central nervous system (CNS) following a variety of viral 
infections (Coutelier et al., 1995, Parra et al., 1997, Trinchieri, 2003, Novelli and 
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Casanova, 2004); however, its contribution to virus resistance varies depending 
upon tissue tropism and predominant effector mechanisms employed to control 
virus replication.  For example, IL12 is critical to control murine cytomegalovirus, 
while it is dispensable for immune responses to lymphocytic choriomengitis virus; 
IFNγ is nevertheless required for resistance to both these infections (Orange and 
Biron, 1996b, Oxenius et al., 1999, Novelli and Casanova, 2004). Although IFNγ 
is a critical component in the protective host immune response to many viruses, 
not all viral infections are associated with IL12 mediated enhancement of the 
IFNγ response (Novelli and Casanova, 2004, Trinchieri, 2003).     
 IL23 shares both the IL12p40 subunit and the IL12 receptor (IL12R) β1 
subunit with IL12 (Hunter, 2005, Trinchieri, 2003, Langrish et al., 2004) and 
similar to IL12, IL23 is primarily secreted by macrophages and dendritic cells.  
The role(s) of IL23 in innate and adaptive immunity have only recently begun to 
come to light (Hunter, 2005, Langrish et al., 2004). A primary consequence is 
induction of CD4 T cells secreting IL17, which play a prominent role in neutrophil 
recruitment to sites of inflammation (Aggarwal et al., 2003, Kolls and Linden, 
2004, Langrish et al., 2004, McGeachy and Cua, 2008). Unlike the IL12R, IL23R 
is not expressed by naïve T cells but is present on memory T cells (McGeachy 
and Cua, 2008). Differential receptor expression is consistent with IL23 
independent induction of IL17 secreting CD4 T cells (Langrish et al., 2004, 
McGeachy and Cua, 2008); however, it is required for sustained expression of 
autoimmune T cell effector function associated with autoimmune demyelination 
of the CNS (Cua et al., 2003, McGeachy and Cua, 2008). During chronic 
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mycobacterial and HIV infections IL23 functions as a regulator of the protective 
IFNγ response (Khader et al., 2005, Novelli and Casanova, 2004) but also 
dampens immune pathology during herpes simplex infection of the eye (Kim et 
al., 2008). However, IL23 has a limited capacity to influence resistance in the 
absence of IL12 (Khader et al., 2005, Lieberman et al., 2004).    
Infection of the CNS with the neurotropic JHM strain of mouse hepatits 
virus (JHMV) induces an acute encephalomyelitis accompanied by myelin loss. 
Virus replicates in microglia, astrocytes and oligodendroglia, but only rarely in 
neurons and is controlled by a vigorous inflammatory response localized to the 
CNS (Bergmann et al., 2006).  CD8 T cells exert crucial antiviral functions via 
perforin and IFNγ mediated mechanisms (Bergmann et al., 2006, Bergmann et 
al., 2003, Parra et al., 1999); however, recent data indicates that CD4 T cells 
alone can also mediate virus clearance (Savarin et al., 2008, Stohlman et al., 
2008).  The critical requirement for IFNγ in combating JHMV infection is 
demonstrated by prolonged virus replication, and increased clinical disease and 
mortality in IFNγ deficient mice (Parra et al., 1999).  In the absence of IFNγ, virus 
preferentially resides in oligodendroglia demonstrating a cell specific action of 
IFNγ within the CNS (Gonzalez et al., 2006). Furthermore, morbidity and 
mortality are dramatically increased in JHMV infected immunodeficient recipients 
of CD4 T cells unable to secrete IFNγ (Pewe et al., 2002, Savarin et al., 2008).  
Although demyelination, a hallmark of JHMV infection, is an immune mediated 
manifestation of tissue destruction rather than a direct viral cytopathic effect 
(Bergmann et al., 2006, Matthews et al., 2002), a contribution of IFNγ to myelin 
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loss is controversial. Similar myelin loss in infected IFNγ-/- mice compared to 
controls (Parra et al., 1999), as well as demyelination induced by IFNγ deficient 
CD4 or gamma delta T cells in the context of immunodeficient hosts implicate an 
immune component other than IFNγ in contributing to demyelination (Bergmann 
et al., 2003, Dandekar and Perlman, 2002). By contrast, T cell transferred into 
infected immunodeficient recipients suggest that IFNγ secretion by CD4 T cells 
limits demyelination (Pewe et al., 2002), while IFNγ secretion by CD8 T cells 
contributes to demyelination (Bergmann et al., 2003, Bergmann et al., 2004, 
Pewe and Perlman, 2002). 
IFNγ thus plays a key role in regulating clinical disease, mortality, control 
of virus replication and myelin loss following JHMV infection of the CNS.  To 
determine the contribution of IL12 to JHMV pathogenesis, as well as a possible 
indirect contribution of IL23 to myelin loss, antiviral immune responses and tissue 
damage were examined in infected IL12/IL23 (p40-/-), IL12 (p35-/-), and IL23 (p19-
/-) mice.  The data demonstrate that IL12 enhances the magnitude of the IFNγ 
response in the CNS following infection, albeit without affecting viral control.  
However, decreased clinical disease in IL12 deficient mice indicates that IL12 
induced IFNγ and a concomitant reduction in IL10 contributes to the disability 
associated with JHMV induced encephalomyelitis.  By contrast, no differences in 
demyelination were detected in JHMV infected mice deficient in either IL12 or 
IL23, suggesting that neither of these cytokines influences virus induced 
demyelination.         
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4.3 Results 
4.3.1 IL12 enhances JHMV induced encephalitis 
Increased transcription of IL12p40 occurs within the CNS rapidly following 
JHMV infection (Parra et al., 1997) implicating a possible role for IL12 and/or 
IL23 in the pathogenesis of JHMV encephalitis.  Recent data further suggested 
that IL12p35 mRNA is rapidly induced and that IL23p19 mRNA transcription 
increases subsequent to virus clearance from the CNS (Held et al., 2008). 
However, the latter results were not correlated with IL12p40 mRNA expression. 
As previous reports relied upon semi-quantitative measures of mRNA, we sought 
to confirm the activation of IL12 and/or IL23 during JHMV infection of the CNS by 
real time PCR. Expression of p40 mRNA was below detection levels in the CNS 
of naïve animals, but was rapidly induced following infection (Figure 21), 
consistent with previous data (Parra et al., 1997). Although p40 mRNA declined 
rapidly after day 5 post infection (p.i.), it remained above basal levels to day 14 
p.i.  In contrast to the mRNA encoding the IL12 and IL23 common p40 chain, 
both the IL12 specific p35 subunit and the IL23 specific p19 subunit were 
detected at relatively low levels in the CNS of naïve animals (Figure 21). 
However, expression of both p35 and p19 mRNA remained at or near basal 
levels following JHMV infection (Figure 21). Despite the inability to detect 
upregulation of these mRNAs, the increase of IL12/23 p40 mRNA suggested that 
either IL12 or IL23 may play important roles in the pathogenesis of JHMV. 
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Figure 21.  JHMV infection induces Il12p40 expression within the CNS. Expression of Il12p40, Il12p35, 
and Il23p19 mRNA in the CNSs of JHMV infected mice at various time p.i. The data reflect induction relative 
to Gapdh, using the following formula: (2[CT {GAPDH} - CT {Target}]) X100, where CT is the threshold cycle. The 
data are the means of three mice per time point ± the standard error mean (SEM). (Kapil et al., 2009) 
 
The potential role(s) of IL12 and IL23 on JHMV induced encephalomyelitis 
were thus investigated in IL12/IL-23 deficient (p40-/-) mice.  Following infection of 
wt mice clinical symptoms of encephalitis were initially detected at day 7 p.i., 
progressed to a peak between days 10-12 p.i. and then began to decline (Figure 
22). By contrast, initial onset of symptoms was delayed in p40-/- mice (Figure 22).  
Furthermore, although clinical symptoms in infected p40-/- mice peaked at days 
10-12 p.i. similar to wt mice, severity was substantially reduced (Figure 22).  To 
determine a dominant contribution of either IL12 or IL23 to morbidity, progression 
and severity of clinical disease was examined following infection of mice 
specifically deficient in either IL12 (p35-/-) or IL23 (p19-/-).  Delayed onset, as well 
as a significant reduction in peak symptoms, was only observed following 
infection of IL12 deficient mice (Figure 22).  IL23 deficient mice exhibited no 
difference in onset or maximum clinical symptoms compared to wt mice (Figure 
22).  Mortality was also similar (∼20%) in infected wt and p19-/- mice. By contrast, 
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mortality in infected p35-/- and p40-/- mice was reduced (∼5%) compared to wt 
mice.  These data indicate that IL2, but not IL23, plays a critical role in regulating 
the morbidity and mortality associated with acute viral encephalitis. Subsequent 
studies thus focused on analysis of p35-/- mice. 
 
Figure 22.  IL12 deficiency decreases the symptoms of virus-induced encephalitis. JHMV infected 
p40-/-, p35-/-, and p19-/- mice were examined for disease severity at various times p.i.  The data are 
representative of two separate experiments for each strain with n>20 per experiment ± SEM. * p ≤ 0.05 
(compared to wt). (Kapil et al., 2009) 
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Clearance of infectious virus from the CNS of p35-/- and control mice was 
compared to assess whether reduced morbidity reflected enhanced control of 
virus replication.  Infectious virus peaked in the CNS to similar levels at day 5 p.i. 
It was subsequently controlled with equal efficiency in both groups and by day 14 
p.i. infectious virus was at the limit of detection in both groups of mice (Figure 23).  
The apparent redundancy of IL12 in clearance of infectious virus is consistent 
with the absence of altered CNS virus replication in mice treated with anti-IL12 
antibody (Held et al., 2008). Similarly, no alteration in virus replication within the 
CNS was detected in mice treated with anti-IL23 antibody (Held et al., 2008)  and 
no differences were detected in virus replication or clearance comparing JHMV 
infected p19-/- and wt mice (data not shown). These data indicate that while IL12 
plays an important role in the onset and severity of morbidity, it does not 
influence virus clearance.   
 
 
Figure 23.  IL12 does not influence control of infectious virus. Virus replication in the CNS of p35-/- and 
wt mice following JHMV infection. The data are representative of two independent experiments and show 
the mean of four individual mice per time point ± SEM.  (Kapil et al., 2009) 
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4.3.2 IL12 does not alter CNS inflammation   
Reduced morbidity during acute infection suggested that leukocytes 
infiltration into the CNS might be altered in the absence of IL12. However, 
analysis of CD45hi bone marrow derived inflammatory leukocytes showed no 
difference in overall recruitment into the CNS of JHMV infected p35-/- mice 
compared to wt mice throughout infection (Figure 24A). Recruitment of 
inflammatory cells was also similar following infection of p19-/- mice (data not 
shown).  There were also no differences in recruitment of Ly6G+ neutrophils or 
F4/80+ monocytes within the CD45hi inflammatory populations at any time point 
p.i. in either p35-/- or p19-/- mice (data not shown). Lastly, to determine if reduced 
clinical disease correlated with altered recruitment of T cell subsets, CD8 and 
CD4 T cells within the infiltrating lymphocyte populations were examined.  A 
slight decrease in total CNS infiltrating CD8 T cells was detected in infected p35-/- 
relative to wt mice at days 7 and 10 p.i., which only reached statistical 
significance at day 7 p.i. (Figure 24B).  Virus specific tetramer+ cells specific for 
the dominant S510 epitope encoded within the viral spike glycoprotein comprised 
~ 40% of CD8 T cells at day 7 and ~60% at day 10 p.i. in both groups (data not 
shown). Similar recruitment of virus specific CD8 T cells was consistent with the 
ability of the p35-/- mice to control infectious virus (Figure 23).  The absence of 
IL12 was also associated with a slight decrease in CD4 T cell CNS infiltration 
throughout infection (Figure 24C), reaching statistical significance at day 10 p.i. 
In summary, although IL12 did not affect recruitment of innate immune cells, total 
CD8 and CD4 T cells were reduced at 7 and 10 days p.i., respectively.  
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Figure 24.  Decreased CD4 T cell recruitment into the CNS of p35-/- mice. (A) Flow Cytometric analysis 
of bone marrow derived CD45hi infiltrating cells within the CNS following JHMV infection. Total numbers of 
CD8 T cells (B) and CD4 T cells (C) isolated from the brains of infected mice.  The Data represent the mean 
of three independent experiments ± SEM. (Kapil et al., 2009). 
 
4.3.3 IFNγ is compromised in the absence of IL12  
In addition to its antiviral function (Bergmann et al., 2006, Gonzalez et al., 
2006, Parra et al., 1997), IFNγ has been suggested to regulate clinical symptoms 
during JHMV induced encephalitis (Pewe et al., 2002). IFNγ is primarily secreted 
by activated T cells during JHMV infection, with no contribution by NK cells (Zuo 
et al., 2006, Savarin et al., 2008, Bergmann et al., 2006, Gonzalez et al., 2006).  
Although IL12 is a powerful inducer and enhancer of IFNγ secretion by T cells, 
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IL12 independent activation of IFNγ producing T cells has been described 
following a number of viral infections (Novelli and Casanova, 2004, Trinchieri, 
2003).  Thus, the frequency of CNS derived virus specific T cells producing IFNγ 
was examined.  In the absence of IL12, frequencies of virus specific CD8 and 
CD4 T cells secreting IFNγ were consistently reduced at day 7 p.i. and. Although 
slightly variable between independent assays, on average the frequencies of 
CD4 and CD8 T cells were reduced by 30% - 40% compared to T cells from the 
CNS of wt mice. Overall, the impact of IL12 deficiency was greater on the CD4 T 
cell population at day 7 p.i. (Figure 25B). The enhancing affect of IL12 on IFNγ 
secretion by CD4 T cells becomes especially evident when the data reflect total 
numbers of virus specific T cells per brain (Figure 25C). At day 10 p.i. the 
proportion of IFNγ secreting CD8 T cells was comparable in wt and p35-/- mice 
(~36%); however, the fraction of CD4 T cells secreting IFNγ in the CNS of the  
p35-/- mice remained at ~60% of wt levels (data not shown).  By contrast, no 
difference in the frequency of IFNγ producing CD4 T cells was detected in CLN 
(Figure 25D) or spleen (data not shown), excluding a peripheral impairment of T 
cell activation and expansion.  Furthermore, reduced frequencies of virus specific 
IFNγ producing cells were not attributable to an increase in IL17 secreting cells, 
as these remained below 0.5% in both the CD4 and CD8 T cell compartments in 
wt as well as p35-/- mice (data not shown).  
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Figure 25.  IL12 enhances IFNγ production and Class II expression. Frequencies of CNS derived IFNγ 
secreting T cells at day 7 p.i. (A) CD8 T cells following stimulation with S510 peptide and (B) CD4 T cells 
with M133 peptide. Data are representative of two separate experiments analyzing cells combined from n = 
4-6 individuals (C) Number of CNS derived CD4 T cells producing IFNγ after ex vivo peptide stimulation in 
infected wt and p35-/- mice at days 7 and 10 p.i. Data represent the mean of two independent experiments ± 
SEM. (D) Frequencies of CLN derived IFNγ secreting CD4 T cells at day 7 p.i. following stimulation in 
presence or absence of M133 peptide. Data are representative of two separate experiments analyzing cells 
combined from n = 4-6 individuals (E) IFNγ dependent MHC class II expression on CD45lo microglia (boxed 
cells) at days 7 and 10 p.i.  (F) Cell free homogenates of the infected CNS were examined for IFNγ by 
ELISA. Data show the mean of n= 4 per time point ± SEM and are representative of two separate 
experiments. Asterisks indicate statistical significance p≤ 0.05, compared to wt. (Kapil et al., 2009) 
 
During JHMV infection MHC class II expression on microglia correlates 
with IFNγ levels within the CNS (Bergmann et al., 2003). To determine if the 
absence of IL12 also compromised IFNγ secretion in the CNS in vivo, microglia 
were examined for upregulation of major histocompatibility complex class II 
molecules. Microglia from infected p35-/- mice was indeed characterized by an 
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initial delay in class II expression relative to Wt mice (Figure 25E). However, by 
day 10 p.i. class II expression on microglia was identical in both groups.  IFNγ 
within the CNS was measured by ELISA to assess to what extent the delay in 
class II upregulation correlates with IFNγ protein levels.  In infected Wt mice, 
IFNγ was detectable at day 5 p.i., increased significantly by day 7 p.i., and then 
declined substantially by day 10 p.i. By contrast, in absence of IL12, IFNγ was 
undetectable at day 5 p.i., and only increased modestly by day 7 p.i. (Figure 25F).  
IFNγ levels within the CNS were similarly low in both groups by day 10 p.i. 
(Figure 25F), when infectious virus was already reduced. These data suggest 
that even under optimal re-stimulation conditions, the capacity of T cells derived 
from an IL-12 deficient CNS environment to produce IFNγ is reduced (Figure 
25C). This deficit was more strongly manifested in vivo, where MHC/antigen 
density, and thus T cell stimulation, is more limited.  Significantly reduced IFNγ 
levels in the CNS of p35-/- mice correlated with delayed class II expression on 
microglia and reduced morbidity. Nevertheless, similar and sustained class II 
expression at day 10 p.i. suggested that the reduced IFNγ in the absence of IL12 
were still sufficient to drive optimal class II expression late during infection and 
sustain viral control.   
4.3.4 Viral induced demyelination is IL12 and IL23 independent 
IFNγ is critical for the control of JHMV infection in oligodendroglia 
(Gonzalez et al., 2006, Parra et al., 1999); however, demyelination in the host 
with an otherwise intact immune system is independent of IFNγ (Gonzalez et al., 
2006, Parra et al., 1999).  Although demyelination associated with experimental 
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autoimmune encephalitis is dependent upon IL23 expression (Cua et al., 2003, 
Langrish et al., 2004, McGeachy and Cua, 2008) the mechanism of myelin loss 
following JHMV infection is unclear (Matthews et al., 2002).  Therefore, potential 
alterations in inflammation, demyelination and viral tropism in p35-/- and p19-/- 
mice were compared with Wt mice.  Despite the delayed onset of clinical 
symptoms and reduced severity in p35-/- mice (Figure 22) no difference in 
inflammation or cells expressing viral antigen were detected compared to wt 
(Figure 26). Although a slight increase in myelin loss was apparent in infected 
p35-/- mice (Figure 26) it did not reach statistical significance due to variability 
between individuals.  Similarly, the inability to secrete IL23 did not alter viral 
induced inflammation or demyelination (Figure 26). These data are consistent 
with an IFNγ independent mechanism of demyelination (Gonzalez et al., 2006).  
 
Figure 26.  IL12 and IL23 do not influence viral pathogenesis. Longitudinal sections of spinal cords from 
JHMV infected wt, p35-/- and p19-/- at day 10 p.i.  The extent of demyelination as shown by luxol fast blue 
(LFB). Viral antigen (arrows) detected by immunohistochemical analysis for viral nucleocapsid using mAb 
J.3.3.   Bar = 200 microns.  (Kapil et al., 2009) 
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4.3.5 IL12 regulation of innate cytokine, chemokine and anti-
inflammatory cytokines 
Ameliorated clinical symptoms in the absence of IL12 suggested three 
possible mechanisms: 1) diminished activation of pro-inflammatory genes; 2) 
reduced chemokine expression; or 3) increased activation of anti-inflammatory 
genes. Expression of genes associated with the acute JHMV response or with 
induction or severity of clinical disease were compared in p35-/- and wt mice.  
Based on the crosstalk between IL12 and type I interferons in regulating IFNγ 
responses (Cousens et al., 1997, Cousens et al., 1999, Orange and Biron, 1996b, 
Novelli and Casanova, 2004, Trinchieri, 2003), IFNα4 and IFNβ mRNA levels 
were initially compared. Transcription of both mRNAs in the CNS was reduced by 
~40%-50% in the absence of IL12 (data not shown). Nevertheless, the reduction 
was insufficient to alter infectious virus load or increase the tropism for neurons 
(Figure 26), previously shown to correlate with the inability to respond to IFNα/β 
(Ireland et al., 2008).  IL12 enhances secretion of IFNγ indirectly via enhanced 
IL1β and TNF secretion, thereby initiating production of inducible nitric oxide 
synthase (iNOS) in addition to other IFNγ inducible genes (Novelli and Casanova, 
2004).  Decreased IFNγ in the absence of IL12 was indeed reflected in 
decreased CNS expression of the mRNA encoding iNos (data not shown).  
Furthermore, consistent with their role in regulating clinical symptoms Il6 and Il1β 
mRNA were reduced in infected p35-/- mice at day 5 p.i. (Figure 27A).  However, 
no difference in transcription of these genes was detected at day 7 p.i. (Figure 
27A), when the p35-/- group exhibited a significant decrease in morbidity (Figure 
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22). Although expression of Tnf mRNA was also slightly reduced in the CNS of 
infected IL-12-/- mice at day 5p.i., the difference did not reach statistical 
significance (Figure 27A). These data suggest that the initial decrease in pro-
inflammatory cytokines contributes to the delayed onset of clinical symptoms.   
Reduced recruitment of T cells into the CNS of infected p35-/- mice 
suggested a possible defect in chemokine induction following infection in 
absence of IL12.  However, Cxcl10 mRNA expression was only transiently 
reduced ∼2 fold at day 5p.i. in the absence of IL12. Cxcl10 mRNA increased to 
wt levels by day 7 p.i. and no differences were observed in expression of Cxcl9 
or Ccl5 mRNA (Figure 27B).  Although expression levels were equivalent by day 
7 p.i., early differences presumably shape the responsiveness to chemokines 
and cytokines later during infection, thus maintaining overall decreased morbidity.  
Based on their association with diminished clinical symptoms of EAE 
(Prud'homme, 2000), expression of Tgfβ and IL10 were examined as down 
regulatory candidates in JHMV infected p35-/- mice. In contrast to the pro-
inflammatory cytokines, no significant alterations in Tgfβ mRNA were detected 
relative to wt controls (Figure 27C).  However, IL10 was increased in the CNS of 
p35-/- mice at days 5, 7 and 10 p.i. (Figure 27D).  Decreased morbidity was thus 
associated with decreased expression of pro-inflammatory cytokines as well as 
increased expression of the anti-inflammatory cytokine IL10.  
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Figure 27.  IL12 alters the expression of pro-inflammatory and anti-infammatory cytokines. Brains 
from infected wt and p35-/- mice were compared for mRNA expression of pro-inflammatory cytokines (A) 
Il1β, Il6 and Tnfα; chemokines (B) Cxcl10, Cxcl9 and Ccl5 and the anti-inflammatory cytokines (C) Tgfβ1 
and Tgfβ3 by real time PCR. Expression levels were normalized to Gapdh using the following formula: (2[CT 
{GAPDH} - CT {Target}]) x 1000, where Ct is the threshold cycle. Data represent the mean of three mice per time 
point ± SEM. (D) IL10 levels in brains of infected wt and p35-/- mice determined by the ELISA. Data are 
representative of two experiments (n = 4 per time point) ± SEM.  BD = below detection. Asterisks indicate 
statistical significance p ≤ 0.05, compared to wt. (Kapil et al., 2009) 
 
4.4 Discussion 
IL12 regulates both innate and adaptive immune responses and plays a 
major role in controlling bacterial and intracellular protozoa infections 
predominantly via stimulation of IFNγ (Jouanguy et al., 1999, Langrish et al., 
2004, Trinchieri, 2003). Similarly, IL23 contributes to host defense against 
bacterial infections(Jouanguy et al., 1999, Trinchieri, 2003, Langrish et al., 2004). 
However, many viral infections resolve without IL12 participation (Trinchieri, 
2003) and the contribution(s) of IL23 have not been extensively explored (Held et 
 
 80 
al., 2008, Kim et al., 2008, Kohyama et al., 2007, Novelli and Casanova, 2004). 
Importantly, both cytokines also have the potential to influence the severity of 
pathological lesions and/or clinical disease (Hunter, 2005, Langrish et al., 2004, 
Trinchieri, 2003, Novelli and Casanova, 2004). Rapid CNS induction of IL12p40 
mRNA in a neurotropic coronavirus induced demyelination model (Parra et al., 
1997) thus prompted analysis of the relative contributions of IL12 and IL23 to 
viral clearance and disease severity. Although quantitative PCR analysis 
confirmed upregulation of Il12p40 mRNA (Parra et al., 1997), we were unable to 
detect statistically significant increases in either Il12p35 or Il23p19 mRNA 
following infection. Discrepancies with the previously reported early Il12p35 
mRNA induction and delayed Il23p19 mRNA induction following clearance of 
infectious virus (Held et al., 2008) may reside in distinct viral inoculum doses or 
our quantitative measurements of PCR replicons. Nevertheless, similar kinetics 
of virus control in p35-/-, and p40-/- mice relative to wt mice, are consistent with 
reports demonstrating no enhancing effects of  IL12 on mouse hepatitis virus 
clearance from the liver and CNS  (Held et al., 2008, Schijns et al., 1998). 
Similarly, infected p19-/- mice provided no evidence for IL23 mediated 
enhancement of host defense (data not shown) consistent with our inability 
detect upregulation of p19 transcripts in JHMV infected Wt mice. A transient 
increase in virus replication observed by treatment with anti-IL23 (Held et al., 
2008) could  thus not be confirmed in p19-/-  mice infected with slightly lower virus 
doses.  
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A primary role of IL12 is enhancement of cytolytic activity and IFNγ 
secretion by NK cells as well as T cells (Trinchieri, 2003).  Nevertheless, IL12 
independent T cell activation and IFNγ secretion has been noted following a 
number of viral infections including systemic lymphocytic choriomengitis virus 
infection (Orange and Biron, 1996a) and Influenza virus infection of the 
respiratory tract (Monteiro et al., 1998). This may be attributed to type I IFN, 
which can also promote IFNγ secretion by lymphocytes (Cousens et al., 1999). 
Type I IFN and IFNγ are both essential to control acute JHMV infection as shown 
by the inability of either virus induced IFNα/β or IFNγ alone to achieve protection 
(Ireland et al., 2008, Parra et al., 1999). The absence of an IL12 affect on JHMV 
clearance from the CNS may thus be attributed to the rapid induction of IFNα 
(Ireland et al., 2008), which may act as both an inhibitor of IL12 and enhancer of 
IFNγ production (Cousens et al., 1999). Nevertheless, IFNγ levels were 
significantly decreased in the CNS of p35-/- mice, suggesting that type I IFN was 
insufficient to compensate for the absence of IL12 in augmenting IFNγ responses. 
Indeed, the modest decrease in IFNα/β mRNA levels in p35-/- mice supports a 
role of IL12 in promoting IFNγ responses locally within the CNS. Impaired NK cell 
function in this context was ruled out, as NK cells do not contribute to either IFNγ 
dependent MHC class II expression on microglia or virus control in otherwise 
immune competent mice (Zuo et al., 2006). Reduced IFNγ correlated with 
decreased frequencies as well as total numbers of virus specific CD8 and CD4 T 
cells derived from the CNS of infected p35-/- mice compared to wt mice. However, 
differences were not observed in frequencies of virus specific IFN-γ producing 
 82 
CD4 T cells (Figure 25D) or CD8 T cells (Data not shown) in  CLN or IFNγ 
producing CD4 or CD8 T cells in splenocytes (data not shown), consistent with a 
role of IL12 in directly promoting local T cell mediated IFNγ secretion within the 
CNS. Although control of JHMV in oligodendrocytes, the predominant cell type 
infected, is IFNγ dependent (Gonzalez et al., 2006, Parra et al., 1999), no 
differences in viral tropism, viral antigen distribution or viral clearance were noted 
comparing p35-/- and wt mice. This suggested that the CD8 T cell response in wt 
mice, the dominant adaptive effector response controlling viral replication 
(Bergmann et al., 2006), exceeds the minimum requirement to effectively inhibit 
viral replication. This is supported by similar results in IL15 and B cell deficient 
mice, which also show reduced numbers of virus specific CD8 T cells in the CNS 
following JHMV infection (Ramakrishna et al., 2002, Zuo et al., 2006). 
A striking finding was the early effect of IL12 on clinical disease, without 
alterations in either virus replication or demyelination. A contribution of IL12 to 
clinical symptoms of viral induced encephalitis, independent of virus load, has not 
been previously reported to our knowledge and provides a novel insight into viral 
pathogenesis of the CNS.  The absence of a direct influence of IL12 on tissue 
destruction is consistent with similar findings in infected mice treated with anti-
IL12 antibody (Held et al., 2008) and other models of virus induced demyelination. 
IL12 contributes to limiting Semliki Forest virus infection of neurons, yet has no 
affect on subsequent demyelination (Keogh et al., 2002).  Furthermore IL12 does 
not influence either the acute phase or demyelination induced by Theiler’s murine 
encephalitis virus (Inoue et al., 1998). The contribution of IFNγ to the 
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pathogenesis of CNS disease is complex, as it can act as a prominent mediator 
of pathogenesis during some experimental viral infections, but can also exert 
anti-inflammatory functions and decrease clinical symptoms (Anghelina et al., 
2006, Kim et al., 2008, Savarin et al., 2008), similar to its role in autoimmunity 
(Kelchtermans et al., 2008). For example, inhibition of IFNγ enhances both 
morbidity and mortality following Semliki Forest virus, Theilers murine 
encephalitis virus, and JHMV induced CNS disease (Tomkins et al., 1988, Pullen 
et al., 1994, Parra et al., 1999).  
IFNγ plays a critical role in shaping the inflammatory cells recruited into 
the CNS (Tran et al., 2000). It is thus difficult to assess how increased virus 
replication and altered inflammation, e.g. neutrophil accumulation within the CNS, 
both a result of IFNγ deficiency, contribute to the symptoms of acute encephalitis.  
This dilemma is evidenced by increased clinical symptoms and mortality of JHMV 
infected immunodeficient recipients of immune CD4 donor T cells deficient in 
IFNγ compared to wt CD4 T cells, independent of viral load (Savarin et al., 2008).  
Both neutrophil and monocyte recruitment in to the CNS, as well as pro-
inflammatory cytokine levels were similar in the absence of IL12 at day 7 p.i., 
correlating reduced clinical disease most prominently with reduced IFNγ levels. 
The observation that clinical disease in not reduced in infected IL15-/-, despite 
decreased virus specific CD8 T cells (Zuo et al., 2006), implicates the paucity of 
total and virus specific CD4 T cells in disease amelioration. Although CD4 T cells 
may contribute to viral clearance (Stohlman et al., 2008), they are more 
prominently implicated in the clinical symptoms of encephalitis (Anghelina et al., 
 84 
2006). Deletion of the immunodominant CD4 T cell epitope dramatically reduced 
both clinical symptoms and mortality following a lethal JHMV challenge 
(Anghelina et al., 2006). Similarly, mutations of the Theiler’s murine encephalitis 
virus immunodominant CD4 T cell epitope ameliorate disease (Palma et al., 
2002). Although IL23 dependent IL17 secreting CD4 T cells have recently been 
implicated in enhancing clinical symptoms during CNS autoimmune disease (Cua 
et al., 2003, Langrish et al., 2004) the frequencies of IL17 secreting T cells in the 
JHMV infected CNS remained near background levels in both wt and p35-/- mice. 
A negligible contribution of IL17 secreting T cells during JHMV pathogenesis is 
supported by a similar disease course and demyelination in both p19-/- mice and 
anti-IL23 antibody treated mice (Held et al., 2008) compared to wt mice. In 
contrast to experimental autoimmune encephalitis (Cua et al., 2003, Langrish et 
al., 2004), IL23 does not act as either a positive or negative regulator of viral 
induced CNS inflammation. These data support the notion that the IL12 
dependent increase in virus specific IFNγ secreting CD4 T cells contributes to the 
expression of clinical symptoms. Furthermore, although no evidence for induction 
of anti-inflammatory TGFβ was detected, IL10 was modestly increased in the 
absence of IL12. JHMV infection of IL10-/- mice resulted in increased encephalitis 
suggesting that IL12 dependent limitations on IL10 may also contribute to 
morbidity by increasing CD4 Th1 cell activation.      
In summary, the study of JHMV induced encephalitis in IL12 and IL23 
deficient mice defined IL12, but not IL23, as a controlling element in the 
enhanced expression of clinical symptoms during viral encephalitis. Importantly, 
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the absence of IL12 decreased IFNγ levels within the CNS; however, neither the 
absence of IL12 or IL23 impeded viral clearance or affected demyelination. 
These data support the notion that IL12 contributes to morbidity by enhancing 
IFNγ secreting CD4 T cells and reducing IL10 mediated protection.  
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CHAPTER V 
KINETIC ANALYSIS OF PRO VERSUS ANTI-INFLAMMATORY GENES 
EXPRESSED BY MICROGLIA/MACROPHAGES DURING CORONAVIRUS 
MEDIATED CNS INFECTION 
5.1 Abstract 
The functional state of tissue macrophage, including CNS resident 
microglia, can have a significant impact on inflammation and pathogenic outcome 
in various diseases. Depending on external stimuli macrophages can exist in 
three major different functional states:  the pro-inflammatory (M1) phenotype, 
anti-inflammatory (M2) phenotype, and deactivated phenotype. Microglia 
activation and recruitment of monocytes are among the first host responses to 
JHMV infection of the CNS. In this study we monitored alterations in gene 
expression by microglia and infiltrated macrophages to assess if these 
populations are 1) regulated similarly, and 2) acquire an anti inflammatory 
phenotype as virus is cleared. Initial analysis of IFNγ, Il13 and Il10, stimuli 
regulating macrophage differentiation towards a pro vs anti-inflammatory 
phenotype, respectively, revealed similar upregulation with peak expression of all 
three cytokines at day 7 post infection (p.i.) in total CNS tissue. RNA analysis of 
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purified microglia and infiltrating macrophages showed microglia initially 
expressed the pro-inflammatory Il12p40, but subsequently rapidly upregulated 
anti-inflammatory Il1ra and Ym1/2 (Chitinase like lectins). By contrast, in 
macrophages expression of Il1ra and Ym1/2 peaked at day 3 (p.i.) and rapidly 
declined by day 7 p.i. Nevertheless, a strong effect of IFNγ was reflected by ∼31 
fold increase in expression of the M1 associated iNos gene in both microglia and 
macrophages during peak IFNγ expression at day 7 p.i. Surprisingly, however, 
the M2 specific Arg-1 was also increased by ∼72 fold at day 7 p.i. in both cell 
populations.  Furthermore, phagocytic activity was similar in both microglia and 
macrophages and increased between day 7 and 10 p.i. suggesting increased 
activation. These results indicate that microglia and infiltrating monocytes exhibit 
overall similar regulation of pro and anti inflammatory factors at the population 
level. Moreover, the data suggest that both M1 and M2 populations coexist and 
are driven by early IFNαβ as well as T cell mediated IFNγ and IL10 production.  
5.2 Introduction 
Macrophages are innate immune cells that play a crucial role in regulating 
both innate and adaptive immunity in response to pathogen as well as tissue 
damage. The functional heterogeneity of macrophages, defined by differential 
activation states, was recently highlighted for various disease settings (Colton, 
2009, Gordon, 2007); an overview of distinct stimuli leading to prominent gene 
expression characteristics is provided in Table 5.1.  
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Table 5.1.  
Functional Heterogeneity of Macrophages  
Activation state Stimulating agent General function 
Innate activation LPS, other TLR ligands Phagocytic activity, 
Adaptive immunity 
Classical activated 
(M1) 
IFNγ, TNFα Phagocytic activity, Pro-
inflammatory cytokine 
production, Nitric Oxide 
(NO) production 
Alternative activated 
(M2a; M2) 
IL4, IL13 Increased phagocytic 
activity, Anti-inflammatory 
cytokine production, 
Arginase-1 production, 
tissue repair, 
reconstruction of extra 
cellular matrix 
Acquired deactivation TGFβ, IL10 Immunosuppression 
 
Macrophages are widely distributed in the body and can be categorized 
into circulating monocytes and tissue resident macrophages. In the CNS 
microglia are the resident macrophages, which are originally derived from 
myeloid progenitors in the yolk sacs (Ginhoux et al., 2010). In the adult CNS, 
 89 
microglia are on constant surveillance for any perturbation mediated by injury or 
infection.  
As a consequence of CNS injury or infection microglia activation is 
phenotypically evident by thickening of highly ramified processes.  Similar to and 
in concert with infiltrating macrophages they play an important role in promoting 
inflammation during microbial infection, but also provide protective roles by 
limiting ongoing tissue damage and by clearing cellular debris. These dual roles 
are reflected by the existence of both pro- and anti-inflammatory microglia and 
macrophages in various CNS inflammatory conditions. Multiple sclerosis (MS) is 
associated with both intracerebral M1 and M2 cells (Oleszak et al., 1998, Chiang 
et al., 1996). M2 macrophages were described as foamy cells that can ingest 
myelin-derived lipids and produce anti-inflammatory cytokines (Boven et al., 
2006). The role of pro- and anti-inflammatory microglia and macrophages in MS 
pathology was further assessed using an experimental demyelinating rodent 
model termed Experimental Autoimmune Encephalitis (EAE). While, a balance 
between M1/M2 phenotype of microglia and macrophage resulted in mild EAE, 
an imbalance towards a prominent M1 phenotype promoted relapsing disease 
(Mikita et al., 2011). Similarly, perivascular macrophages and microglia exist in a 
mixed M1/M2 polarized state following HIV infection in the CNS (Benoit et al., 
2008). M1 macrophages were relatively short lived, reduced the level of HIV 
replication but caused neurotoxicity, while an M2 activation state resulted in 
persistent viral infection but maintained neuronal homeostasis (Cassol et al., 
2009). Overall, distinct regulation of microglia relative to infiltrating macrophages, 
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the co-existence of M1/M2 macrophages and microglia, and the relative 
contribution in propagating disease or maintaining recovery during CNS infection 
has not been well studied. 
Microglia and macrophage express a wide array of pathogen recognition 
receptors (PRRs) which can be activated following recognition of pathogen 
associated molecular patterns (PAMPs), such as DNA and RNA structures 
(Takeda et al., 2003). Engagement of PRRs leads to induction of IFNα/β, as well 
as numerous pro-inflammatory cytokines and chemokines (Takeda and Akira, 
2004). IFNα/β also induces transcription of the anti-inflammatory factor Il1ra in 
macrophages (Jungo et al., 2001, Sciacca et al., 2000). IFNα/β can further 
polarize macrophages towards an M2 phenotype following infection with 
Tropheryma whipplei (Al Moussawi et al., 2010). These data highlight the 
plasticity of pro- and anti-inflammatory gene expression by macrophages as a 
result of numerous autocrine as well as paracrine stimuli.  They further suggest 
the integrative outcome of complex signaling pathways is difficult to predict in 
vivo, especially in situations where infiltration by T cells provides prominent 
changes in environmental cues, such as release of IFNγ and IL10.  
 Following intracerebral inoculation, JHMV initially targets ependymal cells 
and spreads to microglia, astrocytes and oligodendroglia, with oligodenrocytes 
being the most prominently infected cell type (Ramakrishna et al., 2004); (see 
Chapter 2). Infection elicits numerous proinflammatory factors resulting in 
recruitment of leukocytes. Driven by CCL2, monocytes constitute the largest 
portion of early CNS infiltrating cells (Savarin et al., 2010), and provide further 
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targets of infection (Ireland et al., 2009). Early infection is characterized mainly 
by pro-inflammatory cytokines, such as TNFα, IL1β, IL1α, IL6 and IL12 
(Bergmann et al., 2006, Parra et al., 1997), with IFNγ only prominent as T cells 
infiltrate the CNS (Parra et al., 1999, Stohlman et al., 1995).  Nevertheless, IL4, 
an anti inflammatory signal, is also induced in response to JHMV infection (Parra 
et al., 1997). In vitro, infection induces IL1β in both primary microglia and 
macrophage and IL1α, IL6 and IL12 are all induced by microglia (Pearce et al., 
1994, Rempel et al., 2004, Rempel et al., 2005, Stohlman et al., 1995). More 
recent data indicate IL10 is prominently produced by T cells (Puntambekar et al., 
2011). These findings suggested JHMV infection induces complex cues with the 
potential to favor both pro- and anti-inflammatory microglia and macrophages. 
 The studies in this chapter thus set out to address three interrelated 
questions:  
1. Are microglia and macrophage skewed from a prominently 
proinflammatory to an anti-inflammatory phenotype as virus is 
controlled or do they reveal a mixed phenotype throughout?  
2.  Do infiltrating macrophages display overall similar gene expression 
profiles as microglia over time, indicating exposure to similar 
environmental cues?  
3. How does IFNαβ influence the microglia/macrophage gene 
expression with respect to M1/M2 associated genes?  
To characterize distinct functional populations, microglia and macrophages were 
isolated from brains of C57Bl/6 mice at various times post JHMV infection and 
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mRNA prepared for real time PCR analysis. We detected induction of both pro- 
and anti-inflammatory factors at the transcript level, suggesting the simultaneous 
existence of both M1 and M2 phenotypes in both microglia and macrophages. 
Moreover, the expression profiles were overall similar between resident microglia 
and the infiltrating macrophages. One exception was high expression of Il1ra in 
early infiltrating monocytes, which was IFNα/β signaling dependent. With the 
exception of early Il1ra, anti-inflammatory markers already increased between 
days 5 and 7 p.i., Phagocytic activity of microglia as well macrophages was also 
increased between days 7 and 10, supporting an increasingly  anti-inflammatory 
phenotype with increased potential to clear dying cells.  
5.3 Results 
5.3.1 The innate phase of JHMV infection is associated with 
abundant monocyte recruitment 
Many approaches study the activation states of macrophages by in vitro 
stimulation with microbial agonist and cytokines (Murray and Wynn, 2011). 
However, in vivo these cell types are subjected to many different signals 
dependent on their localization. Resident tissue macrophages exist in an anti-
inflammatory state by default to minimize continuous inflammation mediated by 
homeostatic cell turnover (Murray and Wynn, 2011). Initial warning signals at the 
site of infection or injury lead to activation of resident macrophages and trigger 
the recruitment of circulating monocytes. During JHMV infection, CCL2 is the 
major chemokine recruiting monocytes to the CNS (Savarin et al., 2010). (Figure 
28) depicts the kinetics on monocyte recruitment and the relative numbers of 
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microglia and monocyte derived macrophages in the CNS during the first week of 
infection. Microglia are characterized as CD45lo F4/80+ cells (Figure 28). 
Infiltrating macrophages exhibit a CD45hiF4/80+ phenotype and comprise ∼75% 
at day 3, and 5 p.i. and ∼69% at day 7 p.i. of total infiltrating populations(Figure 
28). The frequency of macrophages decline subsequently to ∼36% at day 10 p.i. 
(Figure 28). These data reveals macrophages as a major infiltrating population 
early following infection, which declines by 2 weeks p.i. 
 
Figure 28.  Kinetics of CD45hi F4/80+ macrophage, and CD45lo F480+  microglia in the CNS following 
JHMV infection. Representative density plots of CNS derived cells stained with CD45 and F4/80 at day 3, 5, 
7, and 10 p.i. CNS-infiltrating cells contain a prominent population of CD45hi F4/80+ macrophages early 
during the infection, while microglia are represented as CD45lo F4/80+ cells. The data represents three 
separate experiments at each time point, combining cells from 3-4 mice/time point/experiment. 
 
5.3.2 JHMV replicates in microglia and infiltrating macrophages 
early during the infection 
Following intracerebral infection JHMV spreads to a variety of resident 
cells.  Microglia are one of the initial targets for infection consistent with their 
expression of the MHV receptor, carcinoembryonic antigen cell adhesion 
molecule 1 (CECAM-1 or MHVR) (Nakagaki and Taguchi, 2006, Ramakrishna et 
al., 2004). Similarly a subset of infiltrating macrophages is also infected (Ireland 
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et al., 2009). As virus replication drives initial PRR dependent innate responses, 
we compared the relative kinetics of viral replication in microglia and infiltrating 
macrophages by quantifying the level of viral RNA using primers specific for RNA 
encoding the nucleocapsid (N) protein, which are found on both genomic and the 
nested subgenomic RNAs (Baric and Yount, 2000, Schelle et al., 2005). 
Microglia and infiltrating macrophages were purified by FACS and RNA viral N 
RNA expression real time PCR analysis Gapdh as a housekeeping gene. Viral 
RNA expression was maximal at day 3 p.i. and  declined by day 5 and 7 p.i. in 
both microglia and macrophages (Figure 29), indicating innate stimulation 
decreases coincident with decreasing virus. This is indeed confirmed by kinetics 
of Ifnα/β levels in chapter 2.  
 
Figure 29.  Kinetics of viral  RNA in macrophage and microglia. Viral mRNA comprising N-protein 
encoding sequences was measured in microglia and macrophage populations isolated from brains of JHMV 
infected C57/Bl6 mice using real time PCR.  Numbers depict mRNA levels relative to the house keeping 
gene GAPDH using the following formula (2[CT – CT{target}]) x 1000, where CT is the threshold cycle. The 
data represent the average values of pooled cells from 5-6 mice of three individual experiments ± SEM. 
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5.3.3 Activation of microglia/macrophage following JHMV infection 
To further characterize the activation state of microglia and macrophages 
within the CNS early following JHMV infection, we determined the initial induction 
of representative pro- and anti-inflammatory factors.  The pro-inflammatory 
cytokine Il12 p40 was barely detectable in microglia from naïve mice. However, 
we observed ∼200 fold induction in Il12 p40 as early as day 3 p.i. in microglia 
which was subsequently downregulated, but still remained ∼55 fold and ∼5 fold 
higher at day 5 and 7 p.i. respectively, compared to naïve levels (Figure 30). 
Similarly, expression of Il12 p40 peaked at day 3 p.i. in infiltrating macrophages 
and was subsequently reduced. Overall, Il12 p40 expression reflected the 
kinetics and magnitude of virus replication in both populations (Figure 29). These 
data supported a direct correlation between virus infection and induction of Il12 
p40.  
 We also assessed transcription of two genes associated with anti-
inflammatory functions. While IL12 promotes IFNγ secretion, the anti-
inflammatory factor Ym1/2 has been reported to induce expression of the Th2 
cytokines IL13 (yeping cai, 2009, JI). Ym1/2 has been described as secretory 
protein that shares a close homology with chitinases. (Jin et al., 1998). Ym1 and 
Ym2 are isomers sharing ∼91% similarity and therefore many studies do not 
differentiate between these isomers and collectively referred as Ym1/2 proteins. 
In the CNS, Ym1/2 are involved in inducing regeneration of olfactory receptor 
neurons (Giannetti et al., 2004). A second prominent anti-inflammatory mediator, 
which counteracts the innate pro-inflammatory cytokines IL1α and IL1β, is IL1Ra.   
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Figure 30.  Activation of microglia/macrophages early during JHMV infection. Comparison of transcript 
levels for the pro-inflammatory cytokine Il12p40 and anti-inflammatory factors Il1Ra and Ym1/2 in microglia 
and macrophages isolated from brains of C57BL/6 mice following JHMV infection. Data are all relative to 
Gapdh as described in Fig. 29. Data for Il12p40 and Il1Ra is average of two separate experiments ± SEM.  
The data for Ym1/2 is derived from a single experiment. Data is from  pooled cells from 5-6 mice per time-
point. 
 
This antagonist competitively binds to IL1 receptor 1 without inducing signal 
transduction, thereby downregulating IL1α and β activity (Eisenberg et al., 1990, 
Seckinger et al., 1987). IL1Ra is also protective during brain injury (Hutchinson et 
al., 2007). Similar to Il12 p40, microglia from naïve mice exhibited very low 
expression of Il1ra, but expression of Ym1/2 was readily detectable, confirming a 
prominently anti-inflammatory state prior to infection. However, while Il-1ra 
increased ∼74 fold, Ym1/2 expression stayed at basal level levels in microglia at 
day 3 p.i. (Figure 30). Expression of Il1ra was further induced to ∼134 fold at day 
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5 p.i. and still remained ∼52 fold higher over naïve levels at day 7 p.i. (Figure 30). 
Ym1/2 was also increased at day 5 p.i., and  down-regulated by day 7 p.i., but 
the maximal increases was only ∼6 fold relative to its basal expression (Figure 
30). Contrasting delayed induction of anti-inflammatory response genes in 
microglia, Il1ra and Ym1/2 mRNA levels were overall much higher in infiltrating 
macrophages at day 3 p.i. Furthermore, although mRNA levels encoding these 
factors declined progressively in macrophages throughout days 5 and 7, they 
remained at elevated levels compared to microglia (Figure 30).  Overall these 
data suggest that early infiltrating macrophages contribute substantially to an anti 
inflammatory environment. 
5.3.4 Expression of cytokines polarizing pro- and anti-inflammatory 
macrophages in the CNS following JHMV infection 
Virus mediated activation of microglia and macrophages lead to induction 
of various cytokines, which in-turn mediates CNS recruitment of peripherally 
activated T cells. During intracerebral CNS infections initial activation, 
differentiation and expansion of T cells takes place in the draining cervical lymph 
nodes. T cells start accumulating in the CNS as early as day 5 p.i. and increase 
to maximal numbers between days 7 and 10 (Ireland et al., 2009, Kapil et al., 
2009); chapter 4). During this time T cell effector function is further influenced by 
the CNS environment and responsible for clearance of the vast majority of 
infectious virus (Bergmann et al., 2003, Bergmann et al., 2004, Gonzalez et al., 
2006, Parra et al., 1999, Stohlman et al., 1995). The key antiviral mediator is 
IFNγ (Kapil et al., 2009, Parra et al., 1999), while IL10 production by T cells 
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dampens T cell pathogenicity (Lin et al., 1998, Trandem et al., 2011). While IFNγ 
is considered an activating cytokine for macrophages, IL10 mediated signaling to 
macrophages is associated with deactivation. Expression of these cytokines is 
thus likely to play a dominant role in influencing macrophage activity. Figure 31 
shows the relative levels of IFNγ, Il10 and Il13, (a cytokine associated with 
alternative macrophage activation) in the CNS during JHMV infection.  IFNγ 
protein is detectable in the brain as early as day 5 p.i. peaks at day 7 p.i., and is 
significantly reduced, yet still detectable by day 10 (Figure 31). Similarly, the 
deactivation factor Il10, predominantly expressed by CD4 T cells (Puntambekar 
et al., 2011) also peaks at day 7, but stays elevated at day 10 p.i. (Figure 31).  
Finally, the increase in Il13 in the brain followed similar kinetics as IFNγ and Il10, 
peaking at day 7 p.i., albeit at considerable lower overall  levels.  Overall the 
increases and decreases relative to naïve levels were also less pronounced 
(Figure 31). The overall expression profiles of IFNγ, Il13 and Il10 followed similar 
kinetics as previously described for the anti-inflammatory cytokines Tgfβ (Kapil et 
al., 2009) and cytokine Il4 (Parra et al., 1997). These data clearly demonstrate 
expression of cytokines known to polarize macrophages into a both pro- and anti-
inflammatory phenotypes.  
 
 99 
 
Figure 31.  Kinetics of cytokine expression known to polarize distinct microglia/monocyte activation 
states. Protein levels of the pro-inflammatory cytokine IFN-γ was measured using ELISA and are 
represented as ng/brain (n=9 mice/time-point). Anti-inflammatory cytokines IL-13 and IL-10 were measured 
at the transcriptional level using real time PCR (n=6 mice/time-point).  Data are represented as relative to 
GAPDH as depicted in Fig. 29. Values represent the average of three separate experiments ± SEM. 
 
5.3.5 T cell mediated influence on M1/M2 profiles of microglia and 
macrophages following JHMV infection 
IFNγ induces macrophages to produce iNOS, resulting in a classically 
activated M1 phenotype (Nathan et al., 1983). iNOS metabolizes amino acids to 
produce nitric oxide (NO) (Bronte and zenviello, 2005, nat rev immunol). NO 
provides protection against intracellular pathogens, however, if released in to the 
extracellular milieu, it can cause damage to the neurons. In contrast, Th2 
cytokines, IL4, and IL13 induce production of arginase1 and mediate polarization 
of macrophage towards an alternatively activated M2 phenotype (Gordon, 2007). 
Furthermore, overexpression of IL10 in macrophages shown to induce gene 
expression and activity of arginase1 and reduce production of reactive nitrogen 
intermediates (Schreiber et al., 2009). Arginase1, expression initiates shift in 
metabolism of L-arginine from NO production by iNOS towards generation of L-
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ornithine, a precursor for polyamines and collagen, which is important for wound 
healing (Bansal and Ochoa, 2003, Durante et al., 2007).  Furthermore, the 
cytokines IL10 and TGFβ induce a deactivated state in macrophages (Mantovani 
et al., 2004). Based on the presence of both IFNγ and anti-inflammatory 
cytokines (IL4, Il13, IL10 and Tgfβ) in the brain following JHMV infection, we 
monitored microglia and macrophages for expression of the respective signature 
M1 /M2 molecules iNos and Arg-1.  
Expression of iNos was upregulated ∼3 fold at day 5 p.i. and ∼31 fold at 
day 7 p.i. in microglia, compared to naïve levels (Figure 32). Expression of iNos 
was reduced at day 10 p.i. but still remained ∼11fold higher than basal level 
(Figure 32). Expression of iNos in infiltrating macrophages follow the similar 
kinetics as microglia (Figure 32). Increasing iNos levels in both microglia and 
macrophages between days 5 and 7p.i. is consistent with increasing IFNγ 
mediated signaling.  To determine the existence of alternative state 
macrophages, we monitored expression of arginase1. In microglia expression of 
Arg-1 was upregulated ∼8 fold at day 5 p.i. and further increased ∼70 fold at day 
7 p.i. and remained higher at day 10 p.i. relative to basal levels in microglia 
(Figure 32). Similarly, a major increase in Arg-1 was apparent in macrophages 
between days 5 and 7 p.i. (Figure 32). Although, the expression level of Arg-1 
was reduced at day 10 p.i. but still remained elevated compared to day 5 (Figure 
32). Overall, these results demonstrate the co-existance of both M1 and M2 
specific gene patterns in both microglia and macrophages following JHMV 
infection.  However sustained expression of arginase1 in microglia at day 10 p.i. 
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indicates a prevalence of anti-inflammatory phenotype in these cells. The data 
further demonstrate rapid adaptation of macrophages to environmental 
influences exerted by T cells. 
 
Figure 32.  Upregulation of mRNA characteristic of M1/M2. Microglia and macrophages were isolated 
form infected mice by FACS and RNA analyzed for IFNγ mediated upregulation of iNos as a representative 
M1 specific factors and Arg1 as a typical  M2 specific factor. Expression relative to Gapdh was determined 
by real time PCR. The data represent the average values of pooled cells from 5-6 mice of three individual 
experiments ± SEM. 
 
5.3.6 Increasing phagocytic activity of microglia and macrophage 
following infection 
Phagocytosis of myelin debris by activated microglia and macrophages 
was reported to be an essential response to promote regeneration following MS 
(Boven et al., 2006). Furthermore, clearance of dead or dying cells by myeloid 
cells is critical to maintain a healthy microenvironment. To determine the 
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phagocytic activity of microglia and macrophage following JHMV infection we 
incubated brain-derived cells with fluorochrome labeled Ecoli particles (K12 
strain) ex vivo and monitored the uptake in a phagocytic assay.  Both microglia 
and macrophages showed high phagocytic ability at day 7 p.i. which was further 
increased at day 10 p.i. (Figure 33). The uptake was ∼40% at day 7 and ∼80% at 
day 10 p.i. in both microglia and macrophages (Figure 33). Increased phagocytic 
activity in microglia and macrophages as T cells accumulate and virus is 
controlled suggest an overall M2 phenotype. Whether the macrophage 
populations expressing M1 and M2 associated genes segregate into distinct 
populations, or represents a mixed phenotype remains to be determined by in 
situ hybridization. Future studies may also utilize bone marrow derived 
macrophages and primary microglial cultures exposed to external M1 or M2 
specific stimuli to further assess gene expression and phagocytic activity in vitro. 
 
Figure 33.  Phagocytic activity of macrophages and microglia is increased as virus is controlled. 
Phagocytic ability of microglia and macrophages was determined by incubating percol gradient purified brain 
cells with fluorescein (494/518) labeled E coli particles (E2861) at 5 MOI (5 particles per one cell) at day 7 
and day 10 p.i. The data is representative of two separate experiments. Cells were pooled together from 2-3 
mice/time-point/experiment. 
 103 
5.3.7 IFNα/β signaling plays an important role in induction of anti-
inflammatory cytokine IL1Ra  
 IFNα/β induction in microglia initiates induction of various interferon-
stimulated genes (ISGs), not only in the same cells, but also in neighboring cells 
such as oligodenroglia (Chapter 2). These ISGs include pro-inflammatory as well 
as anti-viral genes. However, IFNα/β also display anti-inflammatory properties as 
indicated by their ability to induce IL1Ra (Aman et al., 1994, Palmer et al., 2004). 
The importance of antiviral activity of IFNα/β during JHMV mediated CNS 
infection was established in mice deficient in IFN receptor chain 1 (IFNAR1-/-). 
IFNAR mice exhibited uncontrolled virus replication and pro-inflammatory 
responses and succumbed to infection within 8 days (Ireland et al., 2008). To 
determine the role of IFNα/β in upregulation of Il1ra, we initially monitored IFNα/β 
expression level in microglia and macrophages derived from brain of infected wt 
mice using real time PCR analysis. The levels of IFNα/β transcripts in microglia 
and macrophage correlated closely with viral RNA loads in both cell types (Figure 
34A). Expression of both Ifnα and Ifnβ transcripts peaked at day 3 p.i. in 
macrophages and was subsequently reduced at day 5 and 7 p.i. (Figure 34A). In 
microglia both Ifnα and Ifnβ were upregulated at day 3 p.i.; while Ifnα transcripts 
followed the same trend as in macrophages, expression of Ifnβ peaked at day 5 
p.i. and was reduced at day 7 p.i. (Figure 34A). These data confirmed 
macrophages and microglia as source of IFNα/β in the CNS (Roth-Cross et al., 
2008); Chapter2).    
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We subsequently isolated mononuclear cells from brains of IFNAR-/- mice 
and congenic control C57/Bl6 mice at different time post infection following JHMV 
infection to monitor Il1ra levels. Induction of Il1ra was significantly blocked in both 
microglia and macrophages in absence of IFNα/β signaling (Figure 34B). These 
results suggested that significantly increased expression of pro-inflammatory 
molecules in the CNS of JHMV infected IFNAR-/- mice may not only be attributed 
to uncontrolled viral spread, but also to significantly impaired anti-inflammatory 
Il1ra expression. 
 
Figure 34.  Upregulation of IL1R antagonist mRNA in microglia and macrophage is IFNαβ dependent. 
(A) Ifnα and Ifnβ transcripts in FACS purified microglia and macrophages were determined using real time 
PCR.  Data represent the average of three separate experiments ± SEM. (B). Il1ra transcript levels were 
determined in both microglia and macrophage isolated by FACS from IFNAR-/- and wt mice following JHMV 
infection. The data is from a single experiment. All data is presented as relative to Gapdh. Cells were pooled 
together from 5-6 mice/time-point/experiment. 
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5.4 Discussion 
Microglia and macrophages are dynamic cells, which continuously survey 
their surroundings for pathogenic agents and dangerous signals. In response to 
extracellular signals they maintain cellular homeostasis by phagocytosis of 
cellular debris and toxic substances. At the site of infection or injury, activation of 
microglia and infiltrating macrophages mediates protective effects, but also 
contributes to tissue damage (Yong and Rivest, 2009). This conflicting behavior 
can be attributed to the plasticity of these cell types, as both microglia and 
macrophage can adopt pro- and anti-inflammatory states, thereby exhibiting 
harmful or protective properties (Mantovani et al., 2004, Michelucci et al., 2009, 
Mosser, 2003). Polarization of microglia and macrophage towards an M1 
phenotype is linked to increased production of pro-inflammatory cytokines and 
pathophysiology during HIV induced dementia (HAD) and Alzheimer’s disease 
(AD) (Minagar et al., 2002). Treatment with non-steroid anti-inflammatory drugs 
(NSAIDs) resulted in reduced amyloid plaque burden in mice and reduced risk for 
AD in humans (Stewart et al., 1997, Szekely et al., 2004, Zandi et al., 2002). 
Furthermore, M2 macrophages promote virus survival and persistence (Cassol et 
al., 2009).  
During JHMV infection, microglia/macrophages are prominent cell types 
inducing pro-inflammatory responses, and their uptake of myelin is characteristic 
of ongoing demyelination during viral persistence. To determine the plasticity of 
activation states during JHMV mediated CNS infection, microglia and 
macrophages purified at different times post-infection from infected brains were 
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characterized for pro- and anti-inflammatory phenotypes. Comparative analysis 
of transcriptional regulation following CNS infection by JHMV revealed the 
existence of overlapping pro and anti-inflammatory (M1/M2) polarization in both 
microglia and macrophages. While an early increase in Il12p40 and delayed 
upregulation of IFNγ stimulated iNos readily depicted an M1 phenotype, an early 
transient increase in Ym1/2, followed by delayed upregulation of Arg-1 
characterized an M2 phenotype. A prevelant M2 phenotype coincident with viral 
control was supported by increased phagocytic potential of both microglia and 
macrophages between 7 and 10 days p.i. By contrast, transcription of Il1ra was 
most prominent in infiltrating macrophages during the initial 5 days of infection, 
suggesting a critical role of early accumulating monocytes in dampening 
exacerbated pro-inflammatory responses.     
The coexistence of M1/M2 or presence of mixed phenotype macrophages 
is supported by similar observations in distinct model systems. A transcriptome 
analysis of monocytes during human cytomegalovirus infection reveals an 
atypical mixed M1/M2 phenotype biased towards an M1 phenotype (Chan et al., 
2008). In contrast, patrolling monocytes initially display an M1 phenotype 
following Listeria monocytogens infection, which subsequently changed to an M2 
phenotype during tissue remodeling (Auffray et al., 2007). Furthermore, an 
imbalance in equilibrium of M1/M2 expression towards M1 phenotype in 
microglia and macrophage in brain and blood monocytes has been linked to 
favor relapsing EAE (Mikita et al., 2011). These studies emphasize that distinct 
functional states of microglia/macrophage play a critical role in final outcome of 
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disease. An imbalance between various polarization states can result in early 
termination of protective microbial responses or aggravated progression of 
autoimmune responses.   
IL1Ra is a soluble factor, which competes with IL1 (α and β) for the IL1 
receptor (Carter et al., 1990, Seckinger et al., 1987), thus antagonizing IL1 
mediated inflammation. IL1 is an innate cytokine, which plays a crucial role in 
leukocyte extravasation to site of infection or injury (Tamaru et al., 1998). 
Dysregulation in IL1 is linked with autoimmune and abnormal immune responses 
(Horai et al., 2000, Nicklin et al., 2000). Exogenous administration of IL1 
exacerbates the course of EAE, while administration of IL1Ra suppresses 
disease (Jacobs et al., 1991, Martin and Near, 1995).  IL1Ra production can be 
induced by various different signals including GMCSF, IL3, IL4 and IFNα/β 
(Jenkins and Arend, 1993, Sciacca et al., 2000). Both IFNα and IFNβ can induce 
IL1Ra production in different cell types in vitro, including monocytes (Jungo et al., 
2001, Wan et al., 2008). Importantly, IFNα/β treatment in Hepatitis C viral 
infection as well as in autoimmune disease such as Rheumatoid Arthritis (RA) 
induces IL1Ra production in patients (Cotler et al., 2002, Palmer et al., 2004). 
Consistent with these findings, early expression of Il1ra in microglia and 
macrophages following JHMV infection correlates with peak of induction of Ifnα/β 
in these cell types. Moreover, the significant reduction in Il1ra expression in both 
macrophage and microglia in the absence of IFNα/β signaling (IFNAR-/- mice) 
supports IFNα/β as critical inducers of IL1Ra in the CNS. Elevated 
proinflammatory cytokines in the CNS of infected IFNAR mice further support an 
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anti-inflammatory property of IFNα/β, which may be mediated via IL1Ra following 
JHMV infection. 
In summary, our findings demonstrate the existence of both pro- and anti-
inflammatory microglia and macrophages in the CNS following JHMV infection. 
Moreover, the regulation of characteristic M1 and M2 associated genes in 
microglia follows similar kinetics as in infiltrating macrophages. While monocyte 
recruitment is associated with detrimental responses in EAE, their recruitment 
during JHMV infection does not have adverse consequences (Savarin et al., 
2010), perhaps due to their overall more abundant expression of M2 genes. 
Furthermore, similar disease course when monocyte recruitment is abrogated 
suggests the function of microglia is sufficient to control inflammation.  Finally, 
IFNα/β is not only crucial in controlling viral dissemination with in the CNS 
(Ireland et al., 2008), but is also required for expression of the anti-inflammatory 
factor Il1ra. Overall, the data indicate a delicate interaction between pro and anti-
inflammatory responses in the CNS. 
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CHAPTER VI 
DISCUSSION 
In this thesis we have focused on innate responses following gliatropic 
coronavirus induced encephalomyelitis and how they impact adaptive responses 
and the pathogenesis. Recognition of viruses by various PRRs provides the first 
line of defense by activating the transcription factors, NFkB and Interferon 
Regulatory Factors (IRFs). These early responses limit viral spread by initiating 
transcription and activation of Interferon (IFN) induced antiviral mediators, such 
as RNaseL and double stranded RNA-dependent protein kinase (PKR). However 
they also regulate pro and anti-inflammatory responses, thereby contributing to 
the tissue damage if not appropriately balanced. There is a growing appreciation 
of distinct abilities of resident CNS cells to recognize and respond to 
microorganism, how responses are coordinated following infection in vivo is 
poorly understood.   
Studies in mice defective in type1 IFN signaling (IFNAR-/- mice) 
demonstrated a critical protective role of type1 IFN signaling in preventing virus 
replication and dissemination following peripheral as well as CNS infection 
(Cervantes-Barragan et al., 2007, Ireland et al., 2008). Although plasmacytoid
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dendritic cells (pDCs) were identified as primary type1 IFN inducers in the 
periphery, the contribution of CNS resident cells to IFNα/β production in vivo was 
not dissected. Our analysis of the relative contribution of microglia/macrophages 
and oligodendroglia in vivo initiating and propagating IFNα/β responses following 
coronavirus CNS infection revealed that oligodendroglia are incapable to produce 
IFNα/β. By contrast, despite being infected at lower levels, microglia initiated 
IFNα/β expression. Compared to microglia oligodendroglia also mounted a 
restricted response towards external IFNα/β to induce anti-viral state. Importantly, 
low basal and delayed inducible levels of mRNA encoding components of the 
IFNα/β pathway in oligodendroglia was reflected in increasing viral mRNA levels 
in oligodendroglia at a time when virus was already controlled in microglia. The 
ineffective innate control in oligodendroglia therefore appears to contribute to 
preferential virus spread in this cell types prior to accumulation of T cells with 
anti-viral activity. Nevertheless, although T cells reduce virus load in 
oligodendroglia, virus still persists preferentially cell in this cell type. Whether a 
stronger innate response in oligodendroglia could slow virus replication, thereby 
enhancing the chances of T cells to clear the virus remains to be determined. 
Oligodendroglia have important function other than myelin formation, including 
neuronal support by secreting neurotropic factors as well as in neurotransmission. 
Neurons are cells with little or no regenerative capacity and would be especially 
vulnerable to inflammation-mediated damage. Therefore, limited and narrowly 
focused innate responses to infection by oligodendroglia provides a mechanism 
to avoid attraction of infiltrating cells and to protect their CNS functions. 
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The role of IFN induced anti-viral genes (is largely unknown in the CNS. 
We determined role of two well-described IFN induced antiviral genes, RNaseL 
and Protein Kinase RNA Dependent (PKR) following JHMV infection in the CNS. 
These latent enzymes are constitutively expressed at lower levels and further 
upregulated by IFNαβ. When activated by dsRNA these antiviral molecules can 
directly block viral replication by degrading viral as well as host RNA and by 
inhibiting protein synthesis. Absence of RNaseL resulted in modest increase in 
viral burden specifically in macrophage/microglia following JHMV infection in the 
CNS, without altering overall virus clearance (Ireland et al., 2009). However, 
unexpectedly RNaseL deficiency resulted in increased axonal damage, 
demyelination and mortality (Ireland et al., 2009). As RNaseL played a minimum 
role as an anti-viral factor, we focused on potential role of PKR. PKR activation 
results in phosphorylation of eIF2α, an eukaryotic translation initiation factor and 
Inhibitor of NFkB (Ikb). Where, Phosphorylation of eIF2 leads to inhibition of 
translation in the host as well virus, phosphorylation of IkB leads to activation of 
potent transcription factor NF-kB and transcriptional induction of downstream 
pro- and anti-inflammatory genes. Our studies demonstrated a modest direct 
antiviral role of PKR, but a strong affect on transcriptional regulation of both and 
pro-inflammatory genes such as Il6, Tnfα, Ccl5, Cxcl10, and anti-inflammatory 
genes namely Il10. Surprisingly, reduced Il10 mRNA in the CNS, correlated with 
a direct defect in the ability of CD4 T cells to produce IL10. Furthermore, the 
absence of PKR resulted in increased accumulation of CD4 T cells in the 
perivascular space. Diminished Il10 expression observed in PKR-/- mice was 
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consistent with enhanced and more diffused demyelination. PKR mediated 
regulation of IL10 in CD4 T cells suggested a virus independent effect and was 
consistent with PKR mediated IL10 regulation in macrophages. These results 
confirmed the notion that antiviral factor also play a significant role in immune 
regulation and cellular homeostatic functions during CNS inflammation. It may 
therefore be informative if RNaseL and PKR play a role in non-viral immune 
mediated demyelinating disease. 
During microbial control or injury induced inflammation the host induces 
countermeasures to limit the tissue damage after virus infection. Macrophage 
and microglia have been identified to play an ambivalent role in inflammation 
based on their plasticity to acquire pro to anti-inflammatory phenotype following 
various CNS infection as well as autoimmune model such as EAE. We therefore 
explored role of infiltrating macrophage and microglia in regulation of 
inflammation following JHMV infection. Microglia and infiltrating macrophages 
exhibited mRNA expression characteristic of pro- as well as anti-inflammatory 
responses, indicating co-existence of several activation phenotypes. Overall 
similar expression patterns but different magnitude of gene expression between 
macrophage and microglia, suggests a cell type specific contribution in regulating 
pro and anti-inflammatory responses at different stages of infection. Microglia 
induced IL12p40 expression at ∼200 fold as soon as at day 3 p.i. IL12p40 is a 
common subunit shared by both IL12 and IL23. While IL12 initiates CD4T cells 
towards IFNγ producing Th1 phenotype; IL23 initiates their activation towards 
IL17 producing Th17 phenotype. Our results indicate that IL12 but not IL23 
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deficiency resulted in ameliorated clinical disease without altering virus 
replication or demyelination. Reduced clinical disease in IL12 deficient mice was 
attributed to diminished pro-inflammatory response (Il6, Il1β and IFNγ) and 
increased anti-inflammatory response (IL10). However, reduced level of IFNγ 
was sufficient to control virus replication in the CNS. These results indicate that 
balance between pro and anti-inflammatory cytokines dictate a complex interplay 
between nature of the CNS insult and timing of the cytokine expression during 
disease. 
Therefore, our findings emphasize the importance of cell specific innate 
immune responses following virus mediated CNS infection using coronavirus 
model. These studies further underscores the growing understanding of innate 
immune responses and its collaboration with adaptive immune response to 
combat acute and persistent infection and their role in successful or pathological 
outcome in general and in the CNS.  
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CHAPTER VII 
MATERIALS AND METHODS 
7.1 Mice 
 C57BL/6 (H-2DB) -IL23-deficient (p19-/-) mice were purchased from 
Schering-Plough, Biopharma (Palo Alto, CA).  C57BL/6-IL12- deficient (p35-/-) 
mice as well as -IL12 and -IL23 (p40-/-) double deficient animals were purchased 
from Jackson Laboratory (Bar Harbor, ME). Mice expressing green fluorescent 
protein (GFP) under control of the proteolipid protein (PLP) promoter (PLP-GFP) 
(Fuss et al., 2000) were backcrossed 6 times with C57BL/6 mice prior to use. 
Congenic mice were used in subsequent experiments for deficient in type-1 IFN 
receptor-1 (IFNAR-/-) (Ireland et al., 2008), PKR-/- (Yang et al., 1995) and dual 
deficient in RNaseL and PKR (DRP-/-) (Zhou et al., 1999). Mice were housed 
and bred in an accredited animal facility at the Cleveland Clinic, Cleveland, OH in 
accordance with IACUC guidelines. Age-matched C57BL/6 wild-type mice 
purchased from the National Cancer Institute (Frederick, MD) were used as 
controls in all experiments.  
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7.2 Virus Infection and Clinical Disease 
 6-7 week old mice were restrained and given an intracerebral injection of 
250 plaque forming units (PFU) of the neutralizing monoclonal antibody (mAb) - 
derived neurotropic John Howard Mueller strain of mouse hepatitis virus (JHMV), 
variant 2.2v-1, in 30μl of endotoxin free Dulbecco’s modified phosphate-buffered 
saline (PBS). In PKR studies, virus was used at 1000 PFU. Severity of clinical 
disease was based on post-infection scores graded as 0 = healthy, 1 = ruffled fur 
and hunch back, 2 = reduced mobility & inability to upright, 3 = paralysis and 
wasting, and 4 = moribund or dead (Fleming et al., 1986). 
7.3 Intracranial Inoculation of Poly (I:C) 
TLR3 ligand Poly (I:C) (high molecular weight) was purchased from 
Invivogen, suspended in endotoxin-free phosphate buffered saline (PBS) to a 
final concentration of 200 µg/30 µl, aliquoted and stored at -20o C until use. Six 
week old C57BL/6 mice were injected intracerebrally with 200 µg poly (I:C) in 30 
µl sterile PBS, similar to the JHMV infections as described.  Brains and spinal 
cords were removed at 2, 6, 12, and 24, post inoculation, snap frozen in liquid 
nitrogen, processed and analyzed for mRNA expression.  
7.4 Isolation of the Mononuclear Cells and Determination of the Virus Titer 
Mononuclear cells were isolated from brain, spleen and cervical lymph 
nodes (CLN) as previously described (Ireland et al., 2008). Briefly, spleen and 
CLN tissues were dissociated, washed, and resuspended in RPMI supplemented 
with 25mM HEPES at 7.2 pH. Additionally, splenocytes were treated with Gey’s 
solution to lyse red blood cells. Brain mononuclear cells were isolated from 
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individual tissues homogenized in 4 ml of Dulbecco’s PBS using chilled Ten-
Broeck glass homogenizers (7 ml). Following centrifugation at 400 x g  for 7 
minutes, clarified supernatants were collected and stored at -80°C. The brain cell 
pellet was resuspended in a final concentration of 30% Percoll (Pharmacia, 
Uppsala, Sweden), underlaid with 1 ml of 70% Percoll, and the gradient was 
centrifuged for 30 min at 800 x g at 4°C. Mononuclear cells were collected from 
the interface between the 30 and 70% Percoll layers, washed twice with RPMI-
HEPES and then viable cells were counted using a hemocytometer-based trypan 
blue exclusion assay. Virus titer in clarified brain supernatants was determined 
by plaque assay on a monolayer of DBT cells (a continuous murine astrocytoma 
cell line), as previously described (Fleming et al., 1986). Briefly, DBT cells were 
grown in RPMI supplemented with 7% new born calf serum (NBC) and 10% TPB 
in 20mm petri dish. After 72 hours, confluent monolayer of DBT cells were 
washed once with RPMI supplemented with TPB and infected with 200µl of brain 
supernatant, either undiluted or at 10, 100 or 1000 fold dilutions at various time 
p.i.  After 90 minutes incubation, cells were overlaid with 0.6% agarose in RPMI 
supplemented with 10% TPB. Plaques were counted after 48 hour incubation at 
37o C. 
7.5 Flow Cytometry 
Cells isolated from CNS, Spleen and CLN were incubated with the 10% 
mouse serum and anti-mouse CD16/32 (clone 2.4G2; BD PharMingen, San 
Diego, CA) for 15 minutes on ice to block non-specific binding (Kapil et al., 2009). 
Cells were stained with flurochrome conjugated mAb as described in Table 7.1. 
 117 
To detect JHMV-specific CD8 T cells, cells were stained with PerCP conjugated 
anti-CD8 and PE conjugated tetramer H-2Db-S510. To study the expression of 
MHC on infiltrating macrophages and on resident brain microglia, cells were 
stained with the anti- CD45 and F4/80 (Serotec, Raleigh, NJ). CD45high -F4/80 
positive cells were distinguished as infiltrating macrophages, while CD45low - 
F4/80 positive cells were distinguished as microglia.  
Table 7.1  
Antibodies Utilized in Flow Cytometry 
Antibody Clone Flurochrome vendor 
CD4 RM4-5 FITC BD Pharmingen 
CD8 53-6.7 PE BD Pharmingen 
CD45 30-F11 APC. PerCP BD Pharmingen 
MHC Class II 2G9 PE BD Pharmingen 
Ly6G 1A8 FITC BD Pharmingen 
F4/80 C1:A3-1 APC, PE Serotec 
O4 O4 Na* In house 
H-2Db-S510 tetramer - PE Beckman-Coulter 
 
7.6 Purification of Cells by Flow Activated Cell Sorting (FACS) 
To identify infiltrating macrophages and CNS resident microglia, cells were 
stained with as described previously in section 6.5 with mAb for the surface 
receptor for macrophage, microglia and oligodendroglia. Infiltrating macrophages 
were characterized by their CD45hi/F4/80+ phenotype, while CD45low/F4/80+ cells 
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were distinguished as microglia. Mature oligodendroglia, were isolated utilizing 
transgenic mice (PLP-GFP/B6) that express green fluorescence protein (GFP) 
under control of an oligodendroglia specific promoter for proteolipid protein, PLP, 
to (Fuss et al., 2000) in conjunction with CD45 surface staining. Oligodendroglia 
from IFNAR-/- and Wt control mice were isolated utilizing CD45 and O4 staining. 
O4 antibody from hybridoma supernatant was obtained from Dr. Stephen 
Stohlman or Dr. Bruce Trapp's lab. It was titrated for use against cells isolated 
from PLP-GFP mice and detected with secondary anti-mus IgM (PE). Total 
protein concentration ranged from 0,1-0.5mg/mL. Staining strategy for specific 
cell type is described in Table 7.2. Following staining cells were maintained in 1X 
FACS buffer on ice for sorting. Purified cells were pelleted by centrifugation 400g 
for 7 minutes at 40 C to remove sheath fluid. Cells were resuspended in trizol and 
stored at -800 C. Typical yields for 6-7 naïve spinal cords were 40,000-80,000 
oligodendroglia and 400,000-600,000 microglia. 
Table 7.2  
Classification of Cell Types for Identification by Flow  
Cell type Phenotypic classification 
Mature oligodendroglia CD45-ve GFP+ve (using PLP-GFP 
mice) 
Oligodendroglia CD45-ve O4+ve 
Microglia CD45lo 
Macrophage CD45hi CD11b+ve F4/80+ve 
* O4 antibody from hybridoma supernatant was obtained from Dr. Stephen A. 
Stohlman.  
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7.7 Correlation between Cell Number and Ct Value 
The CNS cell isolation procedure routinely yielded higher numbers of 
microglia and macrophages compared to oligodendroglia (see section 6.6). To 
validate that cell numbers were not a factor limiting detection of low abundance 
mRNA, we evaluated the minimum number of cells needed to achieve reliable 
PCR products by sorting limiting numbers of brain microglia (CD45lo CD11b+) 
from mice inoculated with the synthetic dsRNA mimic poly (I:C) 4h prior to 
isolation. Naïve brains were excluded as Ifnα/β transcripts were to close to 
detection thresholds. RNA was isolated from as few as 7500 cells up to 240,000 
cells and analyzed for relative expression of Gapdh, Ifnα4, and Ifnβ. Ifit1 and Ifit2 
transcripts served as representative ISG. Titration curves show that the Ct values 
for all the genes were in the linear range to Gapdh Ct values (Suppl. Figure 3). 
Ifn4 transcripts that are expressed at low copy number were still in the linear 
range and reliably detected even below 30,000 cells. In the present study, a 
minimum of 30,000-40,000 cells obtained from cell preparations of 6-8 mice were 
thus used for qPCR analysis. 
7.8  Ex Vivo Stimulation Of Splenocytes 
Spleens were isolated 7 day p.i. from mice injected intraperitoneally with 
MHV DMN strain at 500 PFU. Splenocytes were isolated as described previously.  
To bias composition of spleen cells towards CD4 T cells, splenocytes were 
cultured in RPMI medium 1640 supplemented with 10% FCS, 1% L glutamine, 
1% nonessential amino acids, 1% sodium pyruvate, .01% gentamycin and 
βmercaptoethanol with CD4 specific peptide M133 for 5 days. Stimulated cells 
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were utilized to determine ability of these cells to produce intarcellular cytokines 
such as IFNγ and IL10. 
7.9 Intracellular Detection of Cytokines 
Virus-specific production of IFNγ, TNFα and IL17 was evaluated in CNS-, 
spleen- and CLN-derived CD8 and CD4 T cells. 2x106 splenocytes and CLN-
derived cells, and 5x105 CNS-derived cells were incubated with 3x105 El-4 or 
CHB3 feeder cells with or without JHMV-specific peptide for the stimulation of 
CD8 or CD4 T cells. Cells were stimulated either with or without 1μM S510 (CD8-
epitope) or 5 μM M133 (CD4-epitope) peptide/ml in a total volume of 200μl of 
RPMI supplemented with 20% fetal calf serum (FCS) for 5 hr at 37o C with 1μl/ml 
Golgi Stop (BD PharMingen, San Diego, CA). Cytokine production by stimulated 
cells was detected by intracellular flow cytometry, as previously described (Kapil 
et al., 2009, Zuo et al., 2006). Briefly, cells were stained for surface expression of 
CD8, CD4 and CD45, fixed and then permeablized using the Cytofix/Cytoperm 
kit (BD PharMingen) according to the manufacturer’s protocol. Expression of 
intracellular cytokine production was detected using FITC conjugated mAb 
specific for IFNγ, PE conjugated IL17 mAb and APC conjugated IL10 Ab.  Cells 
were analyzed with FACS Calibur flow cytometer (Becton Dickinson, Mountain 
View, CA) using FlowJo software (TreeStar, Inc., Ashland, OR). 
7.10 Phagocytic Assay For Macrophage And Microglia 
Escherichia coli (K-12 strain) BioParticles®, Alexa Fluor® 488 (invitrogen) 
conjugate were used as particle tracers to analyze phagocytosis by infiltrating 
macrophage and resident microglia cells from CNS of wt mice. Briefly, 
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mononuclear cells from brain were incubated along with bioparticles. Before 
using, particles were incubated with opsonizing reagent (invitrogen) in 1xPBS for 
1 hour at 370 C and than washed twice with 1XPBS. Cells were incubated with 
beads for 1 hour at 370 C in 5% CO2 incubator. Cells were than washed 3X to 
remove particles from surface and than blocked and stained for CD45 and F4/80 
as described previously. To avoid nonspecific signal from beads bound to the 
surface of microglia/macrophages, cells were quenched with trypan blue for 5 
minutes at ice and washed 3X to remove extra dye. Cells were analyzed with 
FACS Calibur flow cytometer (Becton Dickinson, Mountain View, CA) using 
FlowJo software (TreeStar, Inc., Ashland, OR). 
7.11 ELISA 
A sandwich enzyme-linked immunosorbent assay (ELISA)-based system 
previously described (Kapil et al., 2009) was used to measure concentrations of 
IFNγ and IL10 protein in brain supernatants.  Briefly, ELISA plates were coated 
with an anti-mouse cytokine capture antibody specific for either IFNγ or IL10 (BD 
PharMingen, San Diego, CA) at 1μg/ml and incubated overnight at 4°C. The 
plates were washed (0.5% Tween-20 in PBS) and blocked with 10% FCS in PBS 
for 1 hr at room temperature and washed again. Brain supernatants collected at 
different time points post-infection were incubated in capture antibody-coated 
ELISA plates for 2 hr at room temperature. Bound cytokine was detected with a 
secondary biotinylated detection antibody specific for either IFNγ or IL10 (BD 
PharMingen) combined with Avidin-Horseradish Peroxidase (Av-HRP) and 
incubated for 1 hr at room temperature. TMB (BD PharMingen) was used as 
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colorometric substrate and the reaction was stopped using sulfuric acid (H2SO4). 
Absorbance levels were measured at 450 nm using a microplate reader (Bio-
Rad) and SoftMax Pro software (Molecular Devices, Sunnyvale, CA). Cytokine 
levels were calculated using a standard curve of known concentrations of 
commercially available recombinant IFNγ or IL10 protein. Triplicate samples 
were averaged and standard error was calculated. Data are presented as ng of 
protein/brain ± SE. 
7.12 Histology and Fluorescent Staining 
Spinal cords were fixed in 10% formalin and embedded in paraffin. 10 μm 
sections were stained with hematoxylin and eosin or luxol fast blue to evaluate 
inflammation and myelin loss, respectively. The distribution of viral antigen was 
determined by immunoperoxidase staining (Vectastain-ABC kit; Vector 
Laboratory, Burlingame, CA), using the anti-JHMV mAb J.3.3 specific for the 
carboxyl terminus of the viral nucleocapsid protein as the primary Ab and horse 
anti-mouse as secondary Ab, and 3, 3' –diamionbenzidine substrate (Vector 
Laboratory). Sections were scored in a blinded manner for inflammation, 
demyelination, and viral antigen.  
To identify accumulation of CD4 T cells within perivascular space, spinal 
cord tissues were isolated from perfused wt and PKR-/- mice as described 
previously (Ireland et al., 2009, Savarin et al., 2010). Tissues were snap frozen in 
liquid N2 in OCT and were stored at -80o C. Spinal cord sections were cut at 
12μm thickness using microtome and stored at -80o C.  Tissue sections were 
thawed and fixed with 4% PFA for 20 minutes each at room temperature. 
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Following permeabilization with 1% tritonX-100 at room temperature, nonspecific 
antibody binding was blocked using 1% bovine serum albumin and 10% goat 
serum. For perivascular accumulation of CD4 T cells, spinal cord sections were 
incubated at 4oC with mouse anti rat CD4 Ab and rabbit anti mouse laminin 
(Cedarline Laboratories, Ontario, Canada) overnight. Next day, tissue sections 
were washed and incubated with AF 594 conjugated anti rat and AF488 
cojugated anti rabbit (Invitrogen) secondary antibodies at room temperature for 
60 minutes. Following wash, sections were mounted with ProLong Gold antifade 
mounting media containing 4′,6-diamidino-2-phenylindole (Invitrogen, Carlsbad, 
CA). To further detrmine expression of PKR-p in CD4 T cells, spinal cord 
sections were incubated at 4oC with mouse anti rat CD4 Ab and rabbit anti 
mouse PKR-p  (Cedarline Laboratories, Ontario, Canada) overnight and 
processed similarly as described previously. 
7.13 Real Time PCR 
  Tissues were immediately frozen in liquid nitrogen and stored at -80°C.  
RNA  was extracted from CNS tissues dissociated in TRIzol Reagent (Invitrogen, 
Carlsbad, CA) using sterile Tenbroeck glass homogenizers according to the 
manufacturer’s instructions.  Briefly, after chloroform extraction, RNA was 
precipitated in isopropyl alcohol, washed with 75% ethanol and resuspended in 
RNase-free water (Gibco, Invitrogen, Grand Island, NY).  To remove DNA 
contamination, RNA was treated with the DNase-treatment Kit (Ambion, Austin, 
TX), according to the manufacturer’s instructions. RNA integrity and 
concentration were evaluated by electrophoresis on a 1.2% formaldehyde 
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agarose gel. cDNA was synthesized using 2 ug of total RNA, Moloney Murine 
Leukemia Virus Reverse Transcriptase (Invitrogen), 10mM dNTP mix, and 20 uM 
random hexamer primers (Promega). Quantitative real-time PCR was performed 
for expression levels of cytokines and chemokines, anti-viral genes and anti-
inflammatory genes was determined using either or SYBR Green chemistry or 
taqman chemistry (Applied Biosystems, Foster city, CA). List of genes is 
described in the table form. Expression was compared relative to the 
endogenous control glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as 
previously described (Ireland et al., 2008). Reaction conditions for the 7500 Fast 
Real-Time PCR system (Applied Bio-system) for SYBR green were as follows: 
95°C for 10 min and 40 cycles of denaturation at 94°C for 10s, annealing at 60°C 
for 30s and elongation at 72°C for 30s and for taqman were 95°C for 20 sec as 
holding temperature and then 40 cycles of denaturation at 95°C for .03s, 
annealing and extension at 60°C for 30s. All PCR were performed in 10 ul final 
reaction volumes consisted of specific master mix, 1mM of each primer, and 4 ul 
cDNA using the ABI 7500 fast PCR machine and 7500 software. Data presented 
reflect the induction level (n fold) relative to GAPDH, using the following formula, 
where Ct is the threshold cycle. 
 
  
(2[CT {GAPDH} - CT {Target}]) x 1000  
 125 
Table 7.3  
List of Primer Sequences/Catalog Number for Genes Utilized in the Study 
Gene Name Primer sequence/ Catalog # 
House keeping gene  
1. Glyceraldehyde 3-
phosphate 
dehydrogenase 
(Gapdh) 
F, 5’-TGCACCACCAACTGCTTAG-3’ 
R, 5’-GGATGCAGGGATGATGTTC-3’ 
 
JHMV primers  
1. Nucleocapsid  gene of 
John Howard Muller 
strain of coronavirus 
(JhmvN) 
F, 5’-GAGTGCCTATTGCCAATGGAA-3’ 
R, 5’-TTAAAGGAACGTCGGTTGTGTCT-3’ 
Cytokines  
1. Interleukin-1β 
(Il1β) 
 
Mm01336189_m1 
 
2. Interleukin-1 receptor 
antagonist 
(Il1Ra) 
F, 5’ AGATAGACATGGTGCCTATTGACCTT-3’ 
R, 5’-CATCTCCAGACTTGGCACAAGA-3’ 
 
3. Interleukin-6 
(Il6) 
F, 5’-ACACATGTTCTCTGGGAAATCGT-3’ 
R, 5’-AAGTGCATCATCGTTGTTCATACA-3’ 
 
4. Interleukin-10 
(Il10) 
F, 5’-TTTGAATTCCCTGGGTGAGAA-3’ 
R, 5’-GCTCCACTGCCTTGCTCTTATT-3’ 
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5. Interleukin-12p35 
(Il12p35) 
F, 5’-CACCCTTGCCCTCCTAAACC-3’ 
R, 5’-CACCTGGCAGGTCCAGAGA-3’ 
 
6. Interleukin-12p40 
(Il12p40) 
F, 5’-ACAGCACCAGCTTCTTCATCAG-3’ 
R, 5’-TCTTCAAAGGCTTCATCTGCAA-3’ 
 
7. Interleukin-13 
(Il13) 
F, 5’-TGACCAACATCTCCAATTGCA-3’ 
R, 5’-TTGTTATAAAGTGGGCTACTTCGATTT-3’ 
 
8. Interleukin-21 
(Il21) 
F, 5’-GGACAGTATAGACGCTCACGAATG-3’ 
R, 5’-CGTATCGTACTTCTCCACTTGCA-3’ 
 
9. Interleukin-23p19 
(Il23p19) 
F, 5’-CAGCAGCTCTCTCGGAAT-3’ 
R, 5’-ACAACCATCTTCACACTGGATACG-3’ 
 
10. Interferon-α4 
(Ifnα4) 
 
Mm00833969_s1 
11. Interferon-β 
(Ifnβ) 
 
Mm00439546_s1 
12. Interferon-γ 
(Ifnγ) 
 
Mm01168134_m1 
13. Tumor necrosis factor-
α 
(Tnfα) 
F, 5’-GCCACCACGCTCTTCTGTCT-3’ 
R, 5’-GGTCTGGGCCATAGAACTGATG-3’ 
 
14. Transforming growth-
factor-β1 
(Tgfβ1) 
F, 5’-CCCGAAGCGGACTACTATGC-3’ 
R, 5’-CGAATGTCTGACGTATTGAAGAACA-3’ 
 
15. Transforming growth-
factor- β3 
F, 5’-CAATTACTGCTTCCGCAACCT-3’ 
R, 5’-AGCACCGTGCTATGGGTTGT-3’ 
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(Tgfβ3) 
Chemo-kines  
1. Chemokine  
(C-C motif)  
ligand 2 (Ccl2) 
F, 5’-AGCAGGTGTCCCAAAGAA-3’ 
R, 5’-TATGTCTGGACCCATTCCTT-3’ 
 
2. Chemokine (C-C motif) 
ligand 5 
(Ccl5/Rantes) 
F, 5’-GCAAGTGCTCCAATCTTGCA-3’ 
R, 5’-CTTCTCTGGGTTGGCACACA-3’ 
 
3. Chemokine (C-X-C 
motif) ligand 9 
(Cxcl9/Mig) 
F, 5’-GACGGTCCGCTGCAACTG-3’ 
R, 5’-GCTTCCCTATGGCCCTCATT-3’ 
 
4. Chemokine (C-X-C 
motif) ligand 10 
(Cxcl10/Ip10) 
F, 5’-TGCACGATGCTCCTGCA-3’ 
R, 5’-AGGTCTTTGAGGGATTTGTAGTGG-3’ 
 
Cell signaling enzymes  
1. Nitric oxide synthetase 
2 (Nos2) 
 
2. Arginase-1 
(Arg1) 
F, 5’ TGGGTGGATGCTCACAGA-3’ 
R, 5’-CAGGTTGCCCATGCAGATT-3’ 
 
3. Chitinase like protein 
 (Ym1/2) 
F, 5’-AATATCTGACGGTTCTGAGGAGTAGA G -3’ 
R, 5’-GGCCAACAGAACAGAAGAAAATG-3’ 
 
Anti-viral factors  
1. Protein Kinase RNA 
dependent 
(Pkr) 
 
Mm00440966_m1 
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2. 2'-5'-oligoadenylate 
synthetase 2 
(Oas2) 
F, 5’-AAAAATGTCTGCTTCTTGAATTCTGA-3’ 
R, 5’-TGTGCCTTTGGCAGTGGAT-3’ 
 
3. Interferon-induced 
protein with 
tetratricopeptide 
repeats 1 
(Ifit1) 
 
Mm00515153_m1 
 
4. Interferon-induced 
protein with 
tetratricopeptide 
repeats 2 
(Ifit2) 
 
Mm00492606_m1 
 
Pathogen Recognition 
Receptors 
 
1. Melanoma 
differentiation-
associated gene-5 
(Mda5) 
F, 5’-GACACCAGAATTCAAGGGAC-3’ 
R, 5’-GCCACACTTGCAGATAATCTC-3’ 
 
2. Retinoic acid inducible 
gene I 
(Rig-I) 
F, 5’-GTCAGCACAAACCACAACC-3’ 
R, 5’-GTCTCAACCACTCGAATGTC-3’ 
 
3. Toll like receptor-2 
(Tlr2) 
 
Mm00442346_m1 
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4. Toll like receptor-3 
(Tlr3) 
 
Mm01207404_m1 
 
5. Toll like receptor-7 
(Tlr7) 
 
Mm00446590_m1 
 
Transcription factor  
1. Interferon regulatory 
factor-3 
(Irf3) 
 
Mm00516779_m1 
 
2. Interferon regulatory 
factor-7 
(Irf7) 
 
Mm00516788_m1 
 
3. Signal Transducers 
and Activators of 
Transcription 
(Stat1) 
 
Mm00439531_m1 
 
4. I-kappa-B kinase 
epsilon 
(Ikkε) 
 
Mm00444862_m1 
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APPENDIX A 
LIST OF ABBREVIATIONS 
wt:  Wild-type 
IL:  Interleukin 
IL1Ra: Interleukin receptor antagonist 
IFN:  Interferon 
Ko:  Knock-out 
IP:  Intra peritoneal 
IC:  Intracerebral 
p.i.:  Post-infection 
NFkB:  Nuclear factor kappa beta 
JHMV: John Howard Muller strain of coronavirus 
PKR:  Protein Kinase RNA dependent 
OAS-2: 2’5’ Oligoadenylate synthetase 
STAT:  Signal transducer and activator of transcription 
IFIT:  Interferon-induced protein with tetratricopeptide repeats 
SC:  Spinal cord 
CD:  Cluster of differentiation 
mAb:  Monoclonal Antibody 
MHC:  Major Histocompatibility Complex 
TNF:  Tumor necrosis factor 
PRR:  Pathogen recognition receptor 
PAMP: Pathogen associated molecular pattern 
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MDA-5: Melanoma Differentiation-Associated Gene 5  
RIG-I:  Retinoic acid inducible gene-I 
TLR:  Toll like receptor 
IRF:  Interferon regulatory factor 
ISG:  Interferon stimulated genes 
CoV:  Coronavirus 
HIV:  Human immunodeficiency virus 
WNV:  West nile virus 
LCMV: Lymphocytic choriomeningitis Virus 
HCMV: Human cytomegalovirus 
HSV:  Herpes simplex virus 
JCV:  John cunningham virus 
EAE:  Experimental autoimmune encephalitis 
MS:  Multiple sclerosis 
Poly I:C: Polyinosinic-polycytidylic acid 
 
 
 
 
 
